• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEF 14A filed by Talkspace Inc.

    4/30/25 5:25:46 PM ET
    $TALK
    Medical/Nursing Services
    Health Care
    Get the next $TALK alert in real time by email
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    SCHEDULE 14A
    (Rule 14a-101)
    INFORMATION REQUIRED IN PROXY STATEMENT
    SCHEDULE 14A INFORMATION
    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934 (Amendment No. )
     
     
     
     
    Filed by the Registrant ☒
     
     
    Filed by a Party other than the Registrant  ☐
     
     
     
     
    Check the appropriate box:
     ☐
    Preliminary Proxy Statement
     ☐
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ☒
    Definitive Proxy Statement
     ☐
    Definitive Additional Materials
     ☐
    Soliciting Material Pursuant to § 240.14a-12
     
    TALKSPACE, INC.
    (Name of Registrant as Specified in its Charter)
     
    Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
     
    Payment of Filing Fee (Check all boxes that apply):
    ☒
    No fee required.
     ☐
    Fee paid previously with preliminary materials.
     ☐
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.


     
    NOTICE & PROXY
    STATEMENT
    Annual Meeting of Stockholders
    June 18, 2025
    9:00 a.m. (Eastern Time)
    TALKSPACE, INC.
    622 THIRD AVENUE NEW YORK, NEW YORK 10017
     
    April 30, 2025
    To Our Stockholders:
    You are cordially invited to attend the Annual Meeting of Stockholders of Talkspace, Inc. (the “Company”) to be held on Wednesday, June 18, 2025, at 9:00 a.m. (Eastern Time). Our Annual Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the virtual Annual Meeting and vote your shares electronically during the meeting by visiting www.virtualshareholdermeeting.com/TALK2025. Utilizing the latest technology and a virtual meeting format will allow stockholders to participate from any location and we expect will lead to increased attendance, improved communications and cost savings for our stockholders and the Company.
    The Notice of Meeting and Proxy Statement on the following pages describe the matters to be presented at the Annual Meeting. Details regarding how to attend the meeting and the business to be conducted at the Annual Meeting are more fully described in the Notice of Annual Meeting and Proxy Statement.
    Whether or not you attend the Annual Meeting, it is important that your shares be represented and voted at the Annual Meeting. Therefore, I urge you to promptly vote and submit your proxy by phone, via the Internet, or, if you received paper copies of these materials, by signing, dating, and returning the enclosed proxy card in the enclosed envelope, which requires no postage if mailed in the United States. Instructions regarding how you can vote are contained on the proxy card or on the instructions that accompanied your proxy materials. If you decide to attend the Annual Meeting, you will be able to vote your shares electronically, even if you have previously submitted your proxy.
    Thank you for your support.
    Sincerely,
    Douglas Braunstein
    Chairman of the Board

    Notice of Annual Meeting of Stockholders
    To be Held on Wednesday, June 18, 2025
    TALKSPACE, INC.
    622 THIRD AVENUE NEW YORK, NEW YORK 10017
    The Annual Meeting of Stockholders (the “Annual Meeting”) of Talkspace, Inc., a Delaware corporation (the “Company”), will be held at 9:00 a.m., Eastern Time, on Wednesday, June 18, 2025. The Annual Meeting will be a completely virtual meeting, which will be conducted via live webcast. You will be able to attend the Annual Meeting electronically by visiting www.virtualshareholdermeeting.com/TALK2025. The Annual Meeting is called for the following purposes:
    1.
    To elect Jon Cohen, Erez Shachar, and Madhu Pawar to serve as the Class I directors until the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified;
    2.
    To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, as the Company’s independent auditors for the fiscal year ending December 31, 2025;
    3.
    To approve, on an advisory basis, the compensation of the Company’s named executive officers; and
    4.
    To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment of the Annual Meeting.
    Holders of record of our outstanding shares of common stock, at the close of business on April 21, 2025, are entitled to notice of and to vote at the Annual Meeting, or any continuation, postponement or adjournment of the Annual Meeting. The Annual Meeting may be continued or adjourned from time to time without notice other than by announcement at the Annual Meeting.
    It is important that your shares be represented at the meeting regardless of the number of shares you may hold. Whether or not you plan to attend the Annual Meeting we urge you to carefully read the enclosed Proxy Statement and the Company’s Annual Report to Stockholders on Form 10-K for the fiscal year ended December 31, 2024 (the “2024 Annual Report”) and vote your shares via the toll-free telephone number or over the Internet, as described in the enclosed materials. If you received a copy of the proxy card by mail, you may sign, date and mail the proxy card in the enclosed return envelope. Promptly voting your shares will ensure the presence of a quorum at the Annual Meeting and will save us the expense of further solicitation. Submitting your proxy now, including by phone or internet, will not prevent you from voting your shares at the Annual Meeting if you desire to do so, as your proxy is revocable at your option.
    By Order of the Board of Directors
    /s/ John C. Reilly
    John C. Reilly
    Chief Legal Officer, EVP Government Relations, and Corporate Secretary
    April 30, 2025
    IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 18, 2025
    This Proxy Statement and the 2024 Annual Report are available at www.proxyvote.com. We will provide without charge to each person to whom this Notice has been delivered (whether by mail or through the Internet), on the request of any such person, additional paper copies per request of the Proxy Statement and 2024 Annual Report, including the consolidated financial statements. Requests should be directed to our investor relations department as described below:
    Talkspace, Inc.
    622 Third Avenue
    New York, New York 10017
    Attention: Investor Relations

    PROXY STATEMENT
    TALKSPACE, INC.
    622 THIRD AVENUE, NEW YORK, NEW YORK 10017
    This proxy statement is furnished in connection with the solicitation by the Board of Directors of Talkspace, Inc. of proxies to be voted at our Annual Meeting of Stockholders to be held on Wednesday, June 18, 2025 (the “Annual Meeting”), at 9:00 a.m., Eastern Time, and at any continuation, postponement, or adjournment of the Annual Meeting. The Annual Meeting will be a completely virtual meeting, which will be conducted via live webcast. You will be able to attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/TALK2025 and entering your 16-digit control number included on your proxy card or on the instructions that accompanied your proxy materials.
    Holders of record of outstanding shares of common stock (“Common Stock”), at the close of business on April 21, 2025 (the “Record Date”), will be entitled to notice of and to vote at the Annual Meeting and any continuation, postponement, or adjournment of the Annual Meeting, and will vote together as a single class on all matters presented at the Annual Meeting. Each share of Common Stock entitles its holders to one vote per share on all matters presented to our stockholders generally. At the close of business on the Record Date, there were 167,368,089 shares of Common Stock issued and outstanding and entitled to vote at the Annual Meeting. We do not have any other outstanding classes of securities entitled to vote at the meeting.
    This proxy statement and the related materials will first be released on or about April 30, 2025, to our stockholders as of the Record Date.
    Unless the contest otherwise requires, references in this proxy statement to:
    •
    “we,” “us,” “our,” the “Company” and “Talkspace” refer to Talkspace, Inc., and, unless otherwise stated, all of its subsidiaries;
    •
    “Business Combination” refers to the transactions contemplated by that certain Agreement and Plan of Merger, dated as of January 12, 2021 (the “Merger Agreement”), by and between Hudson Executive Investment Corp. (“HEC”), Groop Internet Platform, Inc. (“Old Talkspace”), Tailwind Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of HEC (“First Merger Sub”), and Tailwind Merger Sub II, LLC, a Delaware limited liability company (“Second Merger Sub”), including the mergers contemplated by the Merger Agreement whereby: (i) First Merger Sub merged with and into Old Talkspace (the “First Merger”) with Old Talkspace surviving the First Merger, and (ii) immediately following the First Merger and as part of the same overall transaction as the First Merger, Old Talkspace merged with and into Second Merger Sub, with Second Merger Sub surviving the merger as a wholly owned subsidiary of HEC (the “Second Merger”).
    1

    IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON WEDNESDAY, JUNE 18, 2025
    This Proxy Statement and our 2024 Annual Report to Stockholders are available at www.proxyvote.com
    PROPOSALS
     
    At the Annual Meeting, our stockholders will be asked:
    1.
    To elect Jon Cohen, Erez Shachar, and Madhu Pawar to serve as the Class I directors until the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified;
    2.
    To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, as the Company’s independent auditors for the fiscal year ending December 31, 2025;
    3.
    To approve, on an advisory basis, the compensation of the Company’s named executive officers; and
    4.
    To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment of the Annual Meeting.
    We know of no other business that will be presented at the Annual Meeting. If any other matter properly comes before the stockholders for a vote at the Annual Meeting, however, the proxy holders named on the Company’s proxy card will vote your shares in their discretion.
    RECOMMENDATIONS OF THE BOARD
     
    The Board of Directors (the “Board”) recommends that you vote your shares as indicated below. If you return a properly completed proxy card, or vote your shares by telephone or Internet, your shares of Common Stock will be voted on your behalf as you direct. If not otherwise specified, the shares of Common Stock represented by the proxies will be voted, and the Board recommends that you vote:
    1.
    FOR the proposal to elect Jon Cohen, Erez Shachar, and Madhu Pawar to serve until the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified;
    2.
    FOR the proposal to ratify the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, as the Company’s independent auditors for the fiscal year ending December 31, 2025; and
    3.
    FOR the proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers.
    INFORMATION ABOUT THIS PROXY STATEMENT
     
    Why you received this proxy statement. You are viewing or have received these proxy materials because Talkspace’s Board is soliciting your proxy to vote your shares at the Annual Meeting. This proxy statement includes information that we are required to provide to you under the rules of the Securities and Exchange Commission (the “SEC”) and is designed to assist you in voting your shares.
    Notice of Internet Availability of Proxy Materials. As permitted by SEC rules, Talkspace is making this proxy statement and its Annual Report to Stockholders for the fiscal year ended December 31, 2024 (the “2024 Annual Report”) available to its stockholders electronically via the Internet at www.proxyvote.com. On or about April 30, 2025, we mailed to our stockholders a Notice of Internet Availability of Proxy Materials (the “Internet Notice”) containing instructions on how to access this proxy statement and our 2024 Annual Report and vote online. If you received an Internet Notice by mail, you will not receive a printed copy of the proxy materials in the mail unless you specifically request them. Instead, the Internet Notice instructs you on how to access and review all of the important information contained in this proxy statement and 2024 Annual Report. The Internet Notice also instructs you on how you may submit your proxy over the Internet. If you received an Internet Notice by mail and would like to receive a printed copy of our proxy materials, you should follow the instructions for requesting such materials contained in the Internet Notice.
    Printed Copies of Our Proxy Materials. If you received printed copies of our proxy materials, then instructions regarding how you can vote are contained on the proxy card included in the materials.
    2

    Householding. The SEC’s rules permit us to deliver a single set of proxy materials to one address shared by two or more of our stockholders. This delivery method is referred to as “householding” and can result in significant cost savings. To take advantage of this opportunity, we have delivered only one set of proxy materials to multiple stockholders who share an address, unless we received contrary instructions from the impacted stockholders prior to the mailing date. We agree to deliver promptly, upon written or oral request, a separate set of proxy materials, as requested, to any stockholder at the shared address to which a single set of those documents was delivered. If you prefer to receive separate copies of the proxy materials, contact Broadridge Financial Solutions, Inc. at 1-866-540-7095 or in writing at Broadridge, Householding Department, 51 Mercedes Way, Edgewood, New York 11717.
    If you are currently a stockholder sharing an address with another stockholder and wish to receive only one set of future proxy materials for your household, please contact Broadridge at the above phone number or address.
    3

    QUESTIONS AND ANSWERS ABOUT THE 2025 ANNUAL MEETING OF STOCKHOLDERS
    WHO IS ENTITLED TO VOTE AT THE ANNUAL MEETING?
     
    The Record Date for the Annual Meeting is April 21, 2025. You are entitled to vote at the Annual Meeting only if you were a stockholder of record at the close of business on that date, or if you hold a valid proxy for the Annual Meeting. Each share of our Common Stock entitles its holders to one vote per share on all matters presented to our stockholders at the Annual Meeting. At the close of business on the Record Date, there were 167,368,089 shares of Common Stock issued and outstanding and entitled to vote at the Annual Meeting. We do not have any other outstanding classes of securities entitled to vote at the meeting.
    A complete list of these stockholders as of the Record Date will be available on the bottom panel of your screen during the meeting after entering the 16-digit control number included on the Notice of Internet Availability of Proxy Materials or any proxy card that you received, or on the materials provided by your bank or broker.
    WHAT IS THE DIFFERENCE BETWEEN BEING A “RECORD HOLDER” AND HOLDING SHARES IN “STREET NAME”?
     
    A record holder holds shares in his or her name. Shares held in “street name” means shares that are held in the name of a bank or broker on a person’s behalf.
    AM I ENTITLED TO VOTE IF MY SHARES ARE HELD IN “STREET NAME”?
     
    Yes. If your shares are held by a bank, brokerage firm, broker dealer or other nominee holder, you are considered the “beneficial owner” of those shares held in “street name.” If your shares are held in street name, our proxy materials are being provided to you by your bank or brokerage firm, along with a voting instruction card if you received printed copies of our proxy materials. As the beneficial owner, you have the right to direct your bank or brokerage firm how to vote your shares, and the bank or brokerage firm is required to vote your shares in accordance with your instructions. You may not vote your shares electronically at the Annual Meeting unless you receive a valid proxy from your brokerage firm, bank, broker dealer or other nominee holder. If you haven’t received a 16-digit control number, you should contact your bank or broker to obtain your control number or otherwise vote through the bank or broker.
    If your shares are held in “street name” by a bank, brokerage firm, broker dealer or other nominee holder and you wish to vote on the election of Directors and Say on Pay proposals, or to act upon any other non-routine business that may properly come before the Annual Meeting, you should provide instructions to your bank, brokerage firm, broker dealer or other nominee holder. Under the rules of the Nasdaq, if you do not provide your broker with instructions, your broker generally will have the authority to vote on the ratification of the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, as the Company’s independent registered public accounting firm. All other matters at the Annual Meeting are expected to be nonroutine and therefore brokers will not be entitled to vote on a beneficial owner’s behalf without voting instructions or discretionary authority on such matters. Further information on how to vote is outlined in the following sections.
    HOW MANY SHARES MUST BE PRESENT TO HOLD THE ANNUAL MEETING?
     
    A quorum must be present at the Annual Meeting for any business to be conducted. The presence at the Annual Meeting, electronically or by proxy, of the holders of a majority in voting power of Common Stock issued and outstanding and entitled to vote on the Record Date will constitute a quorum. Pursuant to our by-laws, a quorum, once established at a meeting will not be broken by the withdrawal of enough votes to leave less than a quorum.
    WHO CAN ATTEND AND VOTE AT THE 2025 ANNUAL MEETING OF STOCKHOLDERS?  
     
    You may attend and vote at the Annual Meeting only if you were a Talkspace stockholder as of the Record Date, or if you hold a valid proxy for the Annual Meeting. The Annual Meeting will be held entirely online to allow greater participation. You will be able to attend the Annual Meeting by visiting the following website: www.virtualshareholdermeeting.com/TALK2025. You will also be able to vote your shares electronically at the Annual Meeting.
    To participate in the Annual Meeting, you will need the 16-digit control number included on your proxy card or on the instructions that accompanied your proxy materials. The meeting webcast will begin promptly at 9:00 a.m.
    4

    Eastern Time on June 18, 2025. We encourage you to access the meeting prior to the start time. Online check-in will begin at 8:45 a.m., Eastern Time, and you should allow ample time for check-in procedures. If you hold your shares through a bank or broker, instructions should also be provided on the voting instruction card provided by your bank or brokerage firm. If you lose your 16-digit control number, you may join the Annual Meeting as a “Guest,” but you will not be able to vote or access the list of stockholders as of the Record Date.
    WHY A VIRTUAL MEETING?
     
    We are excited to embrace the latest technology to provide expanded access, improved communication and cost savings for us and our stockholders. We believe the virtual meeting will enable increased stockholder attendance and participation since stockholders can participate from any location around the world and save costs relative to holding a physical meeting. Thus, we believe that hosting a virtual meeting is in the best interests of the Company and such attendees of the Annual Meeting.
    WHAT IF DURING THE CHECK-IN TIME OR DURING THE ANNUAL MEETING I HAVE TECHNICAL DIFFICULTIES OR TROUBLE ACCESSING THE VIRTUAL MEETING WEBSITE?
     
    We will have technicians ready to assist you with any technical difficulties you may have accessing the virtual meeting website. If you encounter any difficulties accessing the virtual meeting website during check-in or the meeting itself, please call the technical support number that will be available on the Annual Meeting website.
    WHAT IF A QUORUM IS NOT PRESENT AT THE ANNUAL MEETING?
     
    If a quorum is not present at the scheduled time of the Annual Meeting, the person presiding over the Annual Meeting may adjourn the Annual Meeting until a quorum is present or represented.
    WHAT DOES IT MEAN IF I RECEIVE MORE THAN ONE SET OF PROXY MATERIALS?
     
    It means that your shares are held in more than one account at the transfer agent and/or with banks or brokers. Please vote all of your shares. To ensure that all of your shares are voted, for each set of proxy materials, please submit your proxy by phone, via the Internet, or, if you received printed copies of the proxy materials, by signing, dating and returning the enclosed proxy card in the enclosed envelope.
    HOW DO I VOTE?
     
    We recommend that stockholders vote by proxy prior to the meeting even if they plan to participate in the Annual Meeting and vote electronically during the meeting. If you are a stockholder of record, there are three ways to vote by proxy:
    •
    by Internet-You can vote over the Internet at www.proxyvote.com by following the instructions on the proxy card or on the instructions that accompanied your proxy materials;
    •
    by Telephone-You can vote by telephone by calling 1-800-690-6903 and following the instructions on the proxy card; or
    •
    by Mail-You can vote by mail by signing, dating and mailing the proxy card, which you may have received by mail.
    Internet and telephone voting facilities for stockholders of record will be available 24 hours a day and will close at 11:59 p.m., Eastern Time, on June 17, 2025. Stockholders may vote at the Annual Meeting by visiting www.virtualshareholdermeeting.com/TALK2025 and entering the 16-digit control number included on your proxy card or the instructions that accompanied your proxy materials. The Annual Meeting webcast will begin promptly at 9:00 a.m., Eastern Time, on June 18, 2025.
    If your shares are held in street name through a bank, brokerage firm, broker dealer or other nominee holder, you will receive instructions on how to vote from the bank or broker. You must follow their instructions in order for your shares to be voted. Internet and telephone voting also may be offered to stockholders owning shares through certain bank, brokerage firm, broker dealer and other nominees. They may have different deadlines for voting than those set forth herein for stockholders of record. If your shares are not registered in your own name and you would like to vote your shares at the Annual Meeting, you may visit www.virtualshareholdermeeting.com/TALK2025 and 16-digit
    5

    control number included in the voting instruction card provided to you by your bank or brokerage firm. If you hold your shares in street name and you do not receive a 16-digit control number, you should contact your bank, brokerage firm, broker dealer or other nominee holder to access the meeting and vote. Instructions should also be provided on the voting instruction card provided by your bank or brokerage firm.
    CAN I CHANGE MY VOTE AFTER I SUBMIT MY PROXY?
     
    Yes. If you are a registered stockholder, you may revoke your proxy and change your vote:
    •
    by submitting a duly executed proxy bearing a later date;
    •
    by granting a subsequent proxy through the Internet or telephone;
    •
    by giving written notice of revocation to the Secretary of Talkspace prior to the Annual Meeting; or
    •
    by voting electronically at the Annual Meeting.
    Your most recent proxy card or Internet or telephone proxy is the one that is counted. Your virtual attendance at the Annual Meeting by itself will not revoke your proxy unless you give written notice of revocation to the Secretary before your proxy is voted or you vote electronically during the Annual Meeting. If your shares are held in street name, you may change or revoke your voting instructions by following the specific directions provided to you by your bank or broker, or you may vote electronically during the Annual Meeting.
    WHO WILL COUNT THE VOTES?
     
    A representative of Broadridge Financial Solutions, Inc., our inspector of election, will tabulate and certify the votes.
    WHAT IF I DO NOT SPECIFY HOW MY SHARES ARE TO BE VOTED?
     
    If you submit a proxy but do not indicate any voting instructions, the persons named as proxies will vote in accordance with the recommendations of the Board. The Board’s recommendations are indicated on page 2 of this proxy statement, as well as with the description of each proposal in this proxy statement.
    WILL ANY OTHER BUSINESS BE CONDUCTED AT THE ANNUAL MEETING?
     
    We know of no other business that will be presented at the Annual Meeting. If any other matter properly comes before the stockholders for a vote at the Annual Meeting, however, the proxy holders named on the Company’s proxy card will vote your shares in accordance with their best judgment.
    HOW MANY VOTES ARE REQUIRED FOR THE APPROVAL OF THE PROPOSALS TO BE VOTED UPON AND HOW WILL ABSTENTIONS AND BROKER NON-VOTES BE TREATED?
     
     
     
     
     
     
     
     
     
     
     
    Proposal
     
     
    Votes required
     
     
    Effect of Votes Withheld /
    Abstentions and Broker Non-Votes
     
     
    Proposal 1: Election of Directors
     
     
    The plurality of the votes cast. This means that the three nominees receiving the highest number of affirmative “FOR” votes will be elected as Directors.
     
     
    Votes withheld and broker non-votes will have no effect.
     
     
    Proposal 2: Ratification of Appointment of Independent Auditors
     
     
    The affirmative vote of the holders of a majority in voting power of the votes cast on such matter.
     
     
    Abstentions will have no effect on the outcome of the proposal. We do not expect any broker non-votes on this proposal.
     
     
    Proposal 3: Approval, on an advisory basis, of the compensation of the Company’s named executive officers (“Say on Pay”).
     
     
    The affirmative vote of the holders of a majority in voting power of the votes cast on such matter.
     
     
    Abstentions and broker non-votes will have no effect on the outcome of the proposal.
     
     
     
     
     
     
     
     
     
     
    6

    WHAT IS AN ABSTENTION AND HOW WILL VOTES WITHHELD AND ABSTENTIONS BE TREATED?
     
    A “vote withheld,” in the case of the proposal regarding the election of directors, or an “abstention,” in the case of the two other proposals to be voted on at the Annual Meeting, represents a stockholder’s affirmative choice to decline to vote on a proposal. Votes withheld and abstentions are counted as present and entitled to vote for purposes of determining a quorum. Votes withheld have no effect on the election of directors and abstentions will have no effect on the ratification of the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, or the advisory Say on Pay votes, because they are not counted as “votes cast.”
    WHAT ARE BROKER NON-VOTES AND DO THEY COUNT FOR DETERMINING A QUORUM?  
     
    Generally, broker non-votes occur when shares held by a broker in “street name” for a beneficial owner are not voted with respect to a particular proposal because the broker (1) has not received voting instructions from the beneficial owner and (2) lacks discretionary voting power to vote those shares. A broker is entitled to vote shares held for a beneficial owner on routine matters without instructions from the beneficial owner of those shares. On the other hand, absent instructions from the beneficial owner of such shares, a broker is not entitled to vote shares held for a beneficial owner on non-routine matters. Because broker non-votes are not counted as “votes cast,” they would have no effect on the outcome of those proposals. Broker non-votes count for purposes of determining whether a quorum is present.
    IF I DISSENT ON ANY MATTER TO BE VOTED ON, WHAT ARE MY RIGHTS?
     
    None of Delaware law, our Certificate of Incorporation, or our Bylaws, provides for appraisal or other similar rights for dissenting stockholders in connection with any of the proposals to be voted upon at the Annual Meeting. Accordingly, our stockholders will have no right to dissent and obtain payment for their shares.
    WHERE CAN I FIND THE VOTING RESULTS OF THE 2025 ANNUAL MEETING OF STOCKHOLDERS?
     
    We plan to announce preliminary voting results at the Annual Meeting and we will report the final results in a Current Report on Form 8-K, which we intend to file with the SEC shortly after the Annual Meeting.
    7

    PROPOSALS TO BE VOTED ON
    PROPOSAL 1: ELECTION OF CLASS I DIRECTORS
     
    Our by-laws permit our Board to determine the total number of directors constituting the Board. Our Board is currently comprised of nine (9) directors divided into three classes each with three-year terms. At each annual meeting of stockholders, the successor (which may include the incumbent) to each director whose term then expires will be elected to serve from the time of election and qualification until the third annual meeting of stockholders following such election or, if earlier, such director’s death, resignation or removal, whichever is earliest to occur. The current Class I Directors are Jon Cohen, Erez Shachar and Madhu Pawar; the current Class II Directors are Curtis Warfield, Jacqueline Yeaney and Michael Hansen; and the current Class III Directors are Douglas Braunstein, Swati Abbott, and Liat Ben-Zur. At the Annual Meeting, only the three (3) Class I Directors are to be elected to hold office until the Annual Meeting of Stockholders to be held in 2028 and until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal. The Class II and Class III directors will be up for reelection at the Annual Meetings of Stockholders to be held in 2026 and 2027 respectively.
    If you submit a proxy but do not indicate any voting instructions, the persons named as proxies will vote the shares of Common Stock represented by the proxy for the election as Directors the nominees whose names and biographies appear below. All of the persons whose names and biographies appear below are currently serving as our directors. In the event any of the nominees should become unable to serve or for good cause will not serve as a director, it is intended that votes will be cast for a substitute nominee designated by the Board or the Board may elect to reduce its size. The Board has no reason to believe that the nominees named below will be unable to serve if elected. Each of the nominees has consented to being named in this proxy statement and to serve if elected.
    VOTE REQUIRED
    The proposal regarding the election of directors requires the approval of a plurality of the votes cast. This means that the three nominees receiving the highest number of affirmative “FOR” votes will be elected as Directors. Votes withheld and broker non-votes will have no effect on the outcome of the vote on this proposal.
    RECOMMENDATION OF THE BOARD OF DIRECTORS
     
     
     
     
     
     
    The Board of Directors unanimously recommends a vote FOR the election of the below Director nominees.
     
     
     
     
    8

    NOMINEES FOR DIRECTORS (CURRENT TERM TO EXPIRE AT THE
    2025 ANNUAL MEETING)
     
    The nominees for election to the Board as Class I Directors are as follows:
     
     
     
     
     
     
     
     
     
     
    Name
     
     
    Age
     
     
    Served as a
    Director Since
     
     
    Positions with Talkspace
    Jon Cohen
     
     
    71
     
     
    2022
     
     
    Chief Executive Officer and Director
    Erez Shachar
     
     
    61
     
     
    2021
     
     
    Director
    Madhu Pawar
     
     
    45
     
     
    2021
     
     
    Director
     
     
     
     
     
     
     
     
     
     
    The principal occupations and business experience, for at least the past five years, of each Class I Director are as follows:
     
     
     
     
    DR. JON COHEN, M.D.
     
     
    Age 71
     
     
     
     
    Dr. Cohen has served as Talkspace's Chief Executive Officer since November 2022, and has served as Director since September 2022. Dr. Cohen has served as Executive Chairman of BioReference Laboratories and Senior Vice President of OPKO Health (NASDAQ: OPK) from 2019 until August 2022. From 2009 to 2018, Dr. Cohen served as an executive officer of Quest Diagnostics. Prior to that he served as Senior Advisor to New York Governor David A. Paterson, where he was responsible for all State policy and strategic planning. Dr. Cohen served for six years as Chief Medical Officer at Northwell Health, the largest healthcare system in New York State. As Chief Executive Officer, Dr. Cohen provides valuable insight to the Board on the Company’s day-to-day operations. In addition, we believe Dr. Cohen's extensive experience in the industry and his leadership skills make him an ideal member of our Board.
     
     
     
     
    EREZ SHACHAR
     
     
    Age 61
     
     
     
     
    Mr. Shachar has served as a member of Talkspace, Inc.'s board of directors since August 2017. Mr. Shachar is the co-founder and managing partner of Qumra Capital Management Ltd., a venture capital firm founded in 2014. Since 2004, Mr. Shachar has also served as managing partner of Evergreen Venture Partners Ltd., a venture capital firm, focusing on investment opportunities in technology companies. Mr. Shachar currently serves as a member of the board of directors of several private companies. Mr. Shachar holds a B.Sc from Tel Aviv University in Israel and M.B.A. from the INSEAD Business School. We believe that Mr. Shachar is qualified to serve as a member of our board of directors due to his extensive experience as an investor in many technology, high-growth, companies and his service as a director of several public and private companies.
     
     
     
     
    MADHU PAWAR
     
     
    Age 45
     
     
     
     
    Ms. Pawar has served as a member of Talkspace, Inc.’s board of directors since the consummation of the Business Combination. Ms. Pawar is the SVP of Consumer Innovation, Optum at United Healthcare, where she has served since January 2024 and is the Adjunct Professor of Analytics in Healthcare at Carnegie Mellon University, where she has served since 2020. Prior to joining United Healthcare, Ms. Pawar worked as a Managing Director at Google LLC for five years where she managed the sales analytics and solutions organizations that drove the small and medium business (SMB) Adwords business, with a focus on machine learning and user experience. Ms. Pawar worked at McKinsey & Company for 12 years where she was a Partner in the healthcare systems and services practice. She began her career in software development as part of the Mobile Technologies division of Hewlett Packard’s Research & Development Labs in Singapore. Ms. Pawar has previously served on the board of directors of Mensa Singapore and GirlVentures, a not-for-profit organization. Ms. Pawar holds a Master’s degree in Information Systems Management from Carnegie Mellon University and a Bachelor’s degree in Computer Science from Nanyang Technological University, Singapore. We believe that Ms. Pawar is qualified to serve as a member of our board of directors due to her extensive experience as an executive of high-growth technology companies and her extensive experience as a management consultant in the healthcare industry.
    9

    CONTINUING MEMBERS OF THE BOARD OF DIRECTORS:
    CLASS II DIRECTOR (TERM TO EXPIRE AT THE 2026 ANNUAL MEETING) 
     
    The current members of the Board who are Class II Directors are as follows:
     
     
     
     
     
     
     
     
     
     
    Name
     
     
    Age
     
     
    Served as a
    Director Since
     
     
    Positions with Talkspace
    Curtis Warfield
     
     
    57
     
     
    2021
     
     
    Director
    Jacqueline Yeaney
     
     
    57
     
     
    2021
     
     
    Director
    Michael Hansen
     
     
    64
     
     
    2022
     
     
    Director
     
     
     
     
     
     
     
     
     
     
    The principal occupations and business experience, for at least the past five years, of each Director nominee are as follows:
     
     
     
     
    CURTIS WARFIELD
     
     
    Age 57
     
     
     
     
    Mr. Warfield has served as a member of Talkspace, Inc.’s board of directors since the consummation of the Business Combination. Since August 2016, Mr. Warfield has served as founder, President and Chief Executive Officer of Windham Advisors LLC, a private equity and strategic advisory firm that offers innovative business solutions for companies in the healthcare, real estate, logistics and other industries. In addition, Mr. Warfield has served as Managing Partner of Aligned Health Venture since October 2022. Mr. Warfield previously served as part of the senior leadership team of Anthem, Inc., one of the nation’s largest health insurers from August 2017 to November 2019. From 2007 until 2015, Mr. Warfield served as CEO of NPAS, a healthcare services company. Since August 2018, Mr. Warfield has served on the board of directors of Texas Roadhouse, Inc., a restaurant company, and has served on the board of OneOncology (2021-2023), before the sale to Amerisource Bergen (NYSE:ABC), a company that invests in and collaborates with community oncology practices and served as Chair of the Audit Committee. Mr. Warfield holds a B.S. from the University of Louisville, Kentucky and is a Certified Public Accountant. We believe that Mr. Warfield is qualified to serve as a member of our board of directors due to his extensive experience as an executive of healthcare companies and his service as a director of a public company.
     
     
     
     
    JACQUELINE YEANEY
     
     
    Age 57
     
     
     
     
    Ms. Yeaney has served as a member of Talkspace, Inc.’s board of directors since the consummation of the Business Combination. Since September 2022, Ms. Yeaney has served as a Strategic Advisor for vorteXplore. From August 2019 until August 2022, Ms. Yeaney served as the Chief Marketing Officer at Tableau Software, LLC, a self-service analytics platform owned by Salesforce {NYSE: CRM}. From January 2017 until April 2019, Ms. Yeaney was the Chief Marketing Officer of Ellucian Inc., a provider of software and services for higher education management, and from May 2011 until December 2016, was the Executive Vice President of Strategy and Marketing of Red Hat, Inc, a provider of open source software solutions now owned by IBM. Ms. Yeaney started her career as an officer in the U.S. Air Force, and then spent six years (1996-2002) as a management consultant at the Boston Consulting Group. Ms. Yeaney has served as a board member of Avaya Holdings Corp., a provider of digital communications products, solutions and services, from March 2019 until May 2023. Ms. Yeaney holds a B.S. in electrical engineering from Rensselaer Polytechnic Institute and an M.B.A. from the Massachusetts Institute of Technology. We believe that Ms. Yeaney is qualified to serve as a member of our board of directors due to her extensive experience as an executive of high-growth technology companies, her extensive experience as a management consultant and her experience as a board member of a public company.
     
     
     
     
    MICHAEL HANSEN
     
     
    Age 64
     
     
     
     
    Mr. Hansen has served as a member of Talkspace, Inc.’s board of directors since September 2022. Mr. Hansen has served as Chief Executive Officer of Cengage Group, a global edtech company providing affordable, quality digital products and services that enable student choice, since 2012. Mr. Hansen has deep experience leading organizations through digital transformation. Under his leadership, the more than 100-year-old Cengage has transformed from a traditional print publisher into an education technology company advancing learning through quality digital experiences. Prior to joining Cengage Group, Mr. Hansen served in the CEO position in a variety of large media and information services companies. Earlier in his career, Mr. Hansen was the lead partner and Chairman of the digital convergence practice at the Boston Consulting Group. He was named one of Fast Company’s Most Creative People in Business (2020) for his leadership tackling higher education affordability with the launch of Cengage Unlimited,
    10

    the first all-access subscription platform for the course materials market. He’s twice been recognized as a top CEO by Glassdoor (2018 and 2019). Mr. Hansen is currently a member of the Business Advisory Council for ProPublica, an independent non-profit producer of investigative journalism. Mr. Hansen earned a Master of Law degree from the University of Bonn and a Master of Business Administration degree from Columbia University. We believe that Mr. Hansen is qualified to serve as a member of our Board due to his extensive board and management experience, including as CEO of and consultant to a variety of technology companies focused on consumer choice and alternative distribution platforms.
    CLASS III DIRECTORS (TERMS TO EXPIRE AT THE 2027 ANNUAL MEETING)  
     
    The current members of the Board who are Class III Directors are as follows:
     
     
     
     
     
     
     
     
     
     
    Name
     
     
    Age
     
     
    Served as a
    Director Since
     
     
    Positions with Talkspace
    Douglas Braunstein
     
     
    64
     
     
    2021
     
     
    Director
    Swati Abbott
     
     
    62
     
     
    2023
     
     
    Director
    Liat Ben-Zur
     
     
    48
     
     
    2023
     
     
    Director
     
     
     
     
     
     
     
     
     
     
    The principal occupations and business experience, for at least the past five years, of the Class III Director are as follows:
     
     
     
     
    DOUGLAS L. BRAUNSTEIN
     
     
    Age 64
     
     
     
     
    Mr. Braunstein served as Talkspace, Inc.'s Interim Chief Executive Officer from November 2021 to November 2022, and has served as Chairman of the Talkspace, Inc. board of directors since the consummation of the Business Combination. Mr. Braunstein is the Founder and a Managing Partner of Hudson Executive Capital, and is Vice Chairman at Wells Fargo & Company, where he has served since February 2024. Prior to founding Hudson Executive Capital, Douglas L. Braunstein was the Chief Financial Officer of JPMorgan Chase & Co., or JPMorgan Chase, from 2010 to 2012 and its Vice Chairman from 2013 to 2015. In the role of Chief Financial Officer, Mr. Braunstein led the firm’s global financial operations and navigated the evolving legislative and regulatory landscape in the immediate post-financial crisis environment and served on the firm’s Operating Committee. Prior to his role as Chief Financial Officer of JP Morgan Chase, Mr. Braunstein served in several other leadership roles during his approximately twenty-year career at JPMorgan Chase, including Head of Investment Banking in the Americas, responsible for investment banking and corporate finance in the U.S., Canada and Latin America, Head of Global M&A and Global Industry Coverage and Head of Healthcare Investment Banking, as well as serving on the Investment Bank Management Committee for over ten years. We believe that Mr. Braunstein is qualified to serve as a member of our board of directors due to his extensive financial background, including service as chief financial officer, experience as a director and knowledge of the industry.
     
     
     
     
    SWATI ABBOTT
     
     
    Age 62
     
     
     
     
    Ms. Abbott has served as a member of Talkspace, Inc.’s board of directors since December 2023. Ms. Abbott is an independent consultant and has served as a board member at Ensign Group, Inc. (ENSG), a company providing post-acute care, since January 2020. Ms. Abbott also served on the board of Magellan Health, Inc. (MGLN) from May 2018 until Magellan’s acquisition by Centene in January 2022. Ms. Abbott previously served as the Chief Executive Officer of Blue Health Intelligence (“BHI”) for eleven years (from May 2011 until April 2022), where she led their initiatives to leverage data insights to develop innovative analytics solutions. Prior to joining BHI, Ms. Abbott served as the President of MEDai, a Reed Elsevier company and leading predictive analytics company that assists healthcare payers and providers. Prior to joining MEDai, Ms. Abbott served in multiple roles where she led strategic solutions development for medical management data warehousing, quality assurance and risk management, among other areas. Ms. Abbott holds a Bachelor of Science degree in physics from Delhi University, India. We believe that Ms. Abbott is qualified to serve as a member of our board of directors due to her deep experience leading organizations through data insights and analytical transformations and her extensive leadership experience in the healthcare industry.
    11

     
     
     
     
    LIAT BEN-ZUR
     
     
    Age 48
     
     
     
     
    Ms. Ben-Zur has served as a member of Talkspace, Inc.’s board of directors since December 2023. Ms. Ben-Zur has served as an Entrepreneur in Residence at Storm Ventures, a venture firm that specializes in building enterprise leaders, since April 2023 and as CEO and Managing Director of LBZ Advisory LLC, a consulting firm that specializes in AI strategy, product-led growth and product management coaching, since May 2023. She has also served as a board member at Splashtop Inc., a company providing a range of zero trust, secure remote-desktop software and remote support software, since January 2024, and as an advisory board member at WestRiver Group, an investment company that invests in early and growth stage businesses and concepts, since January 2024 and at Syndio, which provides technology and expert guidance to sustain workplace equity, since December 2023. Prior to this, she served as Corporate Vice President, Consumer Services at Microsoft from September 2018 to May 2023 and as Senior Vice President at Royal Philips from October 2014 to August 2018, where she led digital initiatives. Ms. Ben-Zur holds a Bachelor of Science degree in Electrical Engineering from the University of California, Davis and a Masters of Business Administration from the University of California, Los Angeles Anderson School of Management. We believe that Ms. Ben-Zur is qualified to serve as a member of our board of directors due to her expertise in mobile, IoT, and artificial intelligence and extensive experience in disruptive technologies and product-led growth.
    12

    PROPOSAL 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT AUDITORS
     
    Our Audit Committee has appointed Kost Forer Gabbay & Kasierer, a member of EY Global as the Company’s independent auditors for the fiscal year ending December 31, 2025. Our Board has directed that this appointment be submitted to our stockholders for ratification. Although ratification of our appointment of Kost Forer Gabbay & Kasierer, a member of EY Global is not required, we value the opinions of our stockholders and believe that stockholder ratification of our appointment is a good corporate governance practice.
    Kost Forer Gabbay & Kasierer, a member of EY Global served as our independent auditors for the fiscal year ended December 31, 2024. Neither Kost Forer Gabbay & Kasierer, a member of EY Global nor any of its members has any direct or indirect financial interest in or any connection with us in any capacity other than as our auditors, providing audit and non-audit related services. A representative of Kost Forer Gabbay & Kasierer, a member of EY Global is expected to attend the Annual Meeting, and have an opportunity to make a statement if he or she desires to do so, but will not be available to respond to questions from stockholders.
    In the event that the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global is not ratified by the stockholders, the Audit Committee will consider this fact when it appoints the independent auditors for the fiscal year ending December 31, 2025. Even if the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global is ratified, the Audit Committee retains the discretion to appoint a different independent auditor at any time if it determines that such a change is in the interests of Talkspace.
    VOTE REQUIRED
     
    This proposal requires the approval the majority of votes cast. Abstentions will have no effect on the proposal. Because brokers have discretionary authority to vote on the ratification of the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global, we do not expect any broker non-votes in connection with this proposal.
    RECOMMENDATION OF THE BOARD OF DIRECTORS
     
     
     
     
     
     
    The Board of Directors unanimously recommends a vote FOR the ratification of the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global as the Company’s independent auditors.
     
     
     
     
    13

    REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS  
     
    The Audit Committee has reviewed Talkspace’s audited financial statements for the fiscal year ended December 31, 2024 and has discussed these financial statements with management and Talkspace’s independent registered public accounting firm. The Audit Committee has also received from, and discussed with, Talkspace’s independent registered public accounting firm the matters that they are required to provide to the Audit Committee, including the matters required to be discussed by the Public Company Accounting Oversight Board (“PCAOB”) and the SEC.
    Talkspace’s independent registered public accounting firm also provided the Audit Committee with a formal written statement required by PCAOB Rule 3526 (Communications with Audit Committees Concerning Independence) describing all relationships between the independent registered public accounting firm and Talkspace, including the disclosures required by the applicable requirements of the PCAOB regarding the independent registered public accounting firm’s communications with the Audit Committee concerning independence. In addition, the Audit Committee discussed with the independent registered public accounting firm its independence from Talkspace.
    Based on its discussions with management and the independent registered public accounting firm, and its review of the representations and information provided by management and the independent registered public accounting firm, the Audit Committee recommended to the Board that the audited financial statements be included in Talkspace’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
    Curtis Warfield (Chair)
    Jacqueline Yeaney
    Michael Hansen
    Swati Abbott
    Liat Ben-Zur
    The foregoing report shall not be deemed incorporated by reference by any general statement or reference to this Proxy Statement into any filing under the Securities Act or under the Exchange Act, except to the extent that the Company specifically incorporates this information by reference and shall not otherwise be deemed filed under those Acts.
    INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FEES AND OTHER MATTERS
     
    Set forth below are the fees to our independent registered public accounting firm, Kost Forer Gabbay & Kasierer, a member of EY Global, for services rendered during the fiscal year ended December 31, 2024 (in thousands):
     
     
     
     
     
     
     
    Fee Category
     
     
    Fiscal 2023
     
     
    Fiscal 2024
    Audit Fees
     
     
    $1,288
     
     
    $1,059
    Audit-Related Fees
     
     
    $​—
     
     
    $​—
    Tax Fees
     
     
    $35
     
     
    $​18
    Total Fees
     
     
    $1,323
     
     
    $1,077
     
     
     
     
     
     
     
    AUDIT FEES
     
    Fees for audit services include fees associated with the annual audit, including the audit of internal control over financial reporting, reviews of the Company's quarterly reports on Form 10-Q and statutory audits required internationally. The fees include consents and assistance with, and review of, documents filed with the SEC.
    TAX FEES
     
    Tax fees consist of tax compliance including the review of tax returns and tax advice services.
    14

    AUDIT COMMITTEE PRE-APPROVAL POLICY AND PROCEDURES
    The Audit Committee has adopted a policy (the “Pre-Approval Policy”) that sets forth the procedures and conditions pursuant to which audit and non-audit services proposed to be performed by the independent auditor may be pre-approved. The Pre-Approval Policy generally provides that we will not engage Kost Forer Gabbay & Kasierer, a member of EY Global to render any audit, audit-related, tax or permissible non-audit service unless the service is either (i) explicitly approved by the Audit Committee (“specific pre-approval”) or (ii) entered into pursuant to the pre-approval policies and procedures described in the Pre-Approval Policy (“general pre-approval”). Unless a type of service to be provided by Kost Forer Gabbay & Kasierer, a member of EY Global has received general pre-approval under the Pre-Approval Policy, it requires specific pre-approval by the Audit Committee or by a designated member of the Audit Committee to whom the committee has delegated the authority to grant pre-approvals. Any proposed services exceeding pre-approved cost levels or budgeted amounts will also require specific pre-approval. For both types of pre-approval, the Audit Committee will consider whether such services are consistent with the SEC’s rules on auditor independence. The Audit Committee will also consider whether the independent auditor is best positioned to provide the most effective and efficient service, for reasons such as its familiarity with the Company’s business, people, culture, accounting systems, risk profile and other factors, and whether the service might enhance the Company’s ability to manage or control risk or improve audit quality. All such factors will be considered as a whole, and no one factor should necessarily be determinative.
    15

    PROPOSAL 3: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.  
     
    This proposal gives our stockholders the opportunity to vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers.
    As described in detail under the heading “Executive Compensation,” our executive compensation programs are designed to attract, motivate, and retain our named executive officers, who are critical to our success. Please read “Executive Compensation” beginning on page 25 of this proxy statement for additional details about our executive compensation programs. We are asking our stockholders to indicate their support for our named executive officer compensation as described in this proxy statement. This proposal, commonly known as a “say-on-pay” proposal, gives our stockholders the opportunity to express their views on the compensation of our named executive officers by allowing stockholders to vote “FOR”, “AGAINST” or “ABSTAIN”. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and our compensation philosophy, policies and practices for named executive officers described in this proxy statement. Accordingly, we will ask our stockholders to vote “FOR” the following resolution at the Annual Meeting:
    “RESOLVED, that the Company’s stockholders approve, on an advisory (non-binding) basis, the compensation of the named executive officers, as disclosed in the Company’s Proxy Statement for the 2025 Annual Meeting of Stockholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion.”
    The say-on-pay vote is advisory, and therefore not binding on the Company, the Board or the Compensation Committee. However, the Board and the Compensation Committee value the opinions of our stockholders and intend to consider our stockholders’ views regarding our executive compensation programs.
    VOTE REQUIRED
     
    This proposal requires the affirmative vote of the holders of a majority in voting power of the votes cast (excluding abstentions and broker non-votes) on such matter. Abstentions and broker non-votes will have no effect on the outcome of this proposal.
    RECOMMENDATION OF THE BOARD OF DIRECTORS
     
     
     
     
     
     
    The Board of Directors unanimously recommends a vote FOR the approval, on an advisory basis, of the compensation of our named executive officers.
     
     
     
     
    16

    EXECUTIVE OFFICERS
    The following table identifies our current executive officers:
     
     
     
     
     
     
     
    Name
     
     
    Age
     
     
    Position
    Jon Cohen(1)
     
     
    70
     
     
    Chief Executive Officer and Director
    Ian Harris(2)
     
     
    36
     
     
    Chief Financial Officer
    John C. Reilly(3)
     
     
    59
     
     
    Chief Legal Officer and Corporate Secretary
    Gil Margolin(4)
     
     
    48
     
     
    Chief Technology Officer
    Katelyn Watson(5)
     
     
    46
     
     
    Chief Marketing Officer
     
     
     
     
     
     
     
    (1)
    See biography on page 10 of this proxy statement.
    (2)
    Mr. Harris has served as Talkspace’s Chief Financial Officer since May 2024. Prior to joining Talkspace, Mr. Harris most recently served as Partner and Managing Director at Hudson Executive Capital LP, an alternative investment firm. At Hudson Executive Capital, Mr. Harris led the investment team’s efforts to source, perform diligence, and manage investments in the healthcare, technology, and financial services sectors. Prior to joining Hudson Executive Capital in 2017, Mr. Harris worked at Barclays Capital, the investment banking division of Barclays PLC, where he advised healthcare companies on M&A and capital market activities. Mr. Harris currently serves as a director at Cantaloupe (Nasdaq: CTLP) and Liberated Syndication, Inc. Mr. Harris received a B.A. in Economics and a B.A. in International Relations from Brown University.
    (3)
    Mr. Reilly has served as Talkspace’s Corporate and then General Counsel since March 2011 and presently serves as Talkspace’s Chief Legal Officer. Prior to joining Talkspace, Mr. Reilly was a partner of Hilltop Holdings from 2004-2011, where he managed hospitality and real estate investments for private portfolio investors and acted as a fractional general counsel to several start-up companies. Mr. Reilly previously served as President of Highland Development Corporation, a real estate development company, from 1999 to 2003 where he partnered to build and operate congregate care campuses. Mr. Reilly also previously held several roles at Kapson Senior Quarters Corp., a publicly traded assisted living company, including as Senior Vice President of Acquisitions and Development from 1998 to 1999, Vice President of Development from 1997 to 1998 and Corporate Counsel from 1996 to 1997. Mr. Reilly started his career as a legal associate at Squire, Sanders & Dempsey in Washington DC. Mr. Reilly holds a J.D. from Boston College Law School and a B.A. from the University of Virginia.
    (4)
    Mr. Margolin has served as Talkspace’s Chief Technology Officer since April 2014. Prior to joining Talkspace, Mr. Margolin served as the Director of Product Management at Deutsche Telekom AG, a telecommunications company, from October 2012 to April 2014. Prior to that, Mr. Margolin served as Director of Product Management at SupportSpace, a cloud-based remote services company, from October 2011 to November 2012. Mr. Margolin previously held several roles at Amdocs, a software and services provider to communications and media companies, including as Director of Product Management from October 2009 to November 2011, Architecture Manager from 2007 to 2009, and Engineering Manager from 2004 to 2007. Mr. Margolin holds a B.S. in Computer Science from the University of Tel Aviv.
    (5)
    Ms. Watson has served as the Chief Marketing Officer of Talkspace since October 2022. Prior to Talkspace, Ms. Watson served as the Chief Marketing Officer of Nurx (and then Thirty Madison following their acquisition of Nurx), from October 2018 to September 2022. Prior to Nurx and Thirty Madison, Ms. Watson was the Vice President of Marketing at experience marketplace IfOnly (which became Mastercard Priceless Cities following the acquisition from Mastercard), from February 2014 to August 2018. Prior to IfOnly, Ms. Watson was Director of Marketing at multiple companies including Kabbage, now an American Express company, Shutterfly Inc., and LaQuinta Hotels, a Wyndham company, from February 2007 to February 2014. Ms. Watson has also served as marketing advisor in parallel to full time roles over time for many companies which include former roles at Quickframe, Galore, Fairy, and Minded and current roles at Pixis and BonBon. Ms. Watson holds a B.B.A. from the University of North Texas.
    17

    CORPORATE GOVERNANCE
    GENERAL
     
    Our Board has adopted Corporate Governance Guidelines, a Code of Business Conduct and Ethics, an Insider Trading Compliance Policy and charters for our Nominating and Corporate Governance Committee, Audit Committee, and Compensation Committee to assist the Board in the exercise of its responsibilities and to serve as a framework for the effective governance of Talkspace. You can access our current committee charters, our Corporate Governance Guidelines, our Code of Business Conduct and Ethics and our Insider Trading Compliance Policy in the “Governance” section of the “Investors” page of our website located at www.talkspace.com, or by writing to our offices at P.O. Box 659, Portsmouth, NH 03802.
    BOARD COMPOSITION AND STRUCTURE
     
    Our Board currently consists of nine (9) members: Swati Abbott, Liat Ben-Zur, Jon Cohen, Erez Shachar, Madhu Pawar, Curtis Warfield, Jacqueline Yeaney, Michael Hansen and Douglas Braunstein. Our Board is currently divided into three classes with staggered, three-year terms. The current Class I Directors are John Cohen, Erez Shachar and Madhu Pawar; the current Class II Directors are Curtis Warfield, Jacqueline Yeaney and Michael Hansen; and the current Class III Directors are Douglas Braunstein, Swati Abbott and Liat Ben-Zur. At each annual meeting of stockholders, the successor to each director whose term then expires will be elected to serve from the time of election and qualification until the third annual meeting following election or such director’s death, resignation or removal, whichever is earliest to occur. Any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. The division of our Board into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control of the Company.
    DIRECTOR ATTENDANCE AT ANNUAL MEETING
     
    Although we do not have a formal policy regarding director attendance at the annual meeting, all directors are encouraged to attend. All then-standing directors and director nominees plan to virtually attend the 2025 Annual Meeting.
    DIRECTOR INDEPENDENCE
     
    Our Board of Directors has affirmatively determined that as of December 2024, each of our directors, with the exception of Mr. Casey, Mr. Cohen, and Ms. Pawar, is “independent” as defined under the Nasdaq Rules. Mr. Braunstein is not considered independent because his spouse was employed by the Company as an Executive Officer in 2022. Mr. Cohen is not considered independent because he currently serves as our Chief Executive Officer. Ms. Pawar is not considered independent because of the position she holds at United Healthcare. As part of the Board’s review of the independence of Board members, questionnaires are used on an annual basis (or when a new director is added) to gather input to assist the Nominating and Corporate Governance Committee and the Board in their determinations of the independence of the non-employee directors. In evaluating and determining the independence of the directors, the Board considered that Talkspace may have certain relationships with its directors. Specifically, the Board of Directors considered that certain of our directors are affiliated with significant stockholders of the Company.
    DIRECTOR CANDIDATES
     
    The Nominating and Corporate Governance Committee is responsible for identifying and reviewing the qualifications of potential director candidates and recommending to the Board those candidates to be nominated for election to the Board.
    To facilitate the search process for director candidates, the Nominating and Corporate Governance Committee may solicit our current directors and executives for the names of potentially qualified candidates or may ask directors and executives to pursue their own business contacts for the names of potentially qualified candidates. The Nominating and Corporate Governance Committee may also consult with outside advisors or retain search firms to assist in the search for qualified candidates, or consider director candidates recommended by our stockholders. Once potential
    18

    candidates are identified, the Nominating and Corporate Governance Committee reviews the backgrounds of those candidates, evaluates candidates’ independence from us and potential conflicts of interest, and determines if candidates meet the qualifications desired by the Nominating and Corporate Governance Committee of candidates for election as director.
    In accordance with our Corporate Governance Guidelines, in evaluating the suitability of individual candidates, the Nominating and Corporate Governance Committee may take into account many factors, including: personal and professional integrity, ethics and values; experience in corporate management, such as serving as an officer or former officer of a publicly held company; strong finance experience; relevant social policy concerns; experience relevant to the Company’s industry; experience as a board member or executive officer of another publicly held company; relevant academic expertise or other proficiency in an area of the Company’s operations; experience in cybersecurity, data privacy and artificial intelligence, diversity of expertise and experience in substantive matters pertaining to the Company’s business relative to other board members; diversity of background and perspective, including, but not limited to, with respect to age, gender, race, place of residence and specialized experience; practical and mature business judgment, including, but not limited to, the ability to make independent analytical inquiries; and any other relevant qualifications, attributes or skills. The Board evaluates each individual in the context of the Board as a whole, with the objective of assembling a group that can best perpetuate the success of the business and represent stockholder interests through the exercise of sound judgment using its diversity of experience in these various areas. In determining whether to recommend a director for re-election, the Nominating and Corporate Governance Committee may also consider the director’s past attendance at meetings and participation in and contributions to the activities of the Board.
    Stockholders may recommend individuals to the Nominating and Corporate Governance Committee for consideration as potential director candidates by submitting the names of the recommended individuals, together with appropriate biographical information and background materials, to the Nominating and Corporate Governance Committee, c/o Chief Legal Officer, Talkspace, Inc., P.O. Box 659, Portsmouth, NH 03802. Assuming that appropriate biographical and background material has been provided on a timely basis in accordance with applicable state corporate law, federal securities laws, our Amended and Restated Certificate of Incorporation and our by-laws, the Nominating and Corporate Governance Committee will evaluate stockholder-recommended candidates by following the same process, and applying the same criteria, as it follows for candidates submitted by others.
    COMMUNICATIONS FROM STOCKHOLDERS
     
    Stockholders of the Company may communicate directly with the independent members of the Board or any Chair of a Board committee about corporate governance, corporate strategy, Board-related matters or other substantive matters that our Chief Legal Officer considers to be important for the director(s) to know, by addressing any communications to the intended recipient by name or position in care of: Talkspace, Inc., Attn: Chief Legal Officer, P.O. Box 659, Portsmouth, NH 03802, subject to compliance with the requirements and parameters noted below. Such communications may be made confidentially or anonymously.
    All communications, including stockholder recommendations of director candidates, must be accompanied by the following regarding the person submitting the communication: a statement of the type and amount of the securities of the Company that the person holds, and the address, telephone number and e-mail address, if any, of the person.
    The following types of communications are considered inappropriate for delivery to directors:
    •
    Communications regarding individual grievances or other interests that are personal to the party submitting the communication; and
    •
    Communications that contain offensive, obscene or abusive content.
    Communications deemed to comply with the above requirements and to be appropriate for delivery will be delivered to the applicable director(s) on a periodic basis, generally in advance of each regularly scheduled meeting of the Board. Concerns relating to accounting, internal accounting controls, auditing matters or questionable financial practices will be handled in accordance with the procedures established by the Audit Committee with respect to such matters.
    BOARD LEADERSHIP STRUCTURE
     
    Our Board of Directors exercises its discretion in combining or separating the roles of Chairman of the Board and Chief Executive Officer as it deems appropriate in light of prevailing circumstances. We believe that we, like many
    19

    U.S. companies, are well-served by a flexible leadership structure. Currently, the roles are separated, with Mr. Braunstein serving as Chairman of the Board and Dr. Cohen serving as Chief Executive Officer. Separating these positions allows the Chief Executive Officer to focus on the full-time job of running the Company’s business, while allowing the Chairman to lead the Board in its fundamental role of providing advice to and independent oversight of management. The Board also believes that separating the Chairman and Chief Executive Officer positions provides enhanced independent leadership and oversight for the Company, management and the Board. Our Board is comprised of individuals with extensive experience in finance, retail industry and public company management. For these reasons and because of the strong leadership of Mr. Braunstein as Chairman of the Board and Dr. Cohen as Chief Executive Officer, our Board has concluded that our current leadership structure is appropriate at this time. However, our Board of Directors will continue to consider whether the positions of Chairman of the Board and Chief Executive Officer should be separated or combined at any given time as part of our succession planning process.
    RISK MANAGEMENT AND BOARD OVERSIGHT
     
    Risk assessment and oversight are an integral part of our governance and management processes.
    Management’s Role
    Our management is responsible for our day-to-day risk management activities.
    Management of the Company, including the Chief Executive Officer, Chief Technology Officer (“CTO”), Chief Compliance Officer (“CCO”), who also functions as the Company’s chief information security officer, and the other executive officers, is primarily responsible for managing the risks associated with the business, operations, data privacy and cybersecurity and financial and disclosure controls. Management oversees the enterprise risk management (“ERM”) process. During the course of the year, periodic monitoring, self-assessment and reporting to the Audit Committee are performed by senior management to:
    •
    Update the trending of various enterprise risks;
    •
    Identify and consider new and emerging risks;
    •
    Assess the implementation status and effectiveness of each mitigation strategy; and
    •
    Identify areas for improvement in the mitigation strategies, if any.
    Board Oversight
    Audit Committee
    Our Audit Committee is responsible for overseeing our risk management process. Our Audit Committee focuses on our most significant risks that impact the business, including strategic, operational, and compliance risks, and oversees the implementation of risk mitigation strategies by management. The Audit Committee reviews and discusses with management the risks faced by the Company and the processes by which management assesses and manages these risks, including major financial risks and exposures, as well as cyber-security-related risks and IT-related risks. The Audit Committee also has responsibilities with respect to the Company’s financial and accounting compliance and complaint procedures, internal audit, SOX Compliance program and related person transactions, as more fully set out in its charter. Among other things, the Audit Committee is responsible for establishing and overseeing procedures for the receipt, retention, and treatment of complaints regarding accounting, internal accounting controls or auditing matters and the confidential, anonymous submission by Company employees of concerns regarding questionable accounting or auditing matters.
    The Audit Committee is directly supported in risk oversight by key members of our senior management team, including:
    •
    To assist the Audit Committee with its risk assessment function, Internal Audit has a direct communication channel to the Audit Committee for purposes of reporting or discussing concerns.
    •
    Our Chief Legal Officer has a direct communication channel to the Audit Committee for purposes of discussing or reporting financial misconduct matters with the Audit Committee and/or its individual members. The Chief Legal Officer also provides periodic reports on the Company’s litigation matters.
    •
    The Chief Compliance Officer provides periodic reports to the Audit Committee on the Company’s data privacy and information and infrastructure security programs, including cybersecurity.
    20

    Compensation Committee
    Our Compensation Committee is responsible for overseeing risks related to our compensation programs and human capital management. The Compensation Committee reviews, and discusses with management, risks related to human capital management, including the company’s compensation policies and practices, and CEO and senior officer succession planning. The Compensation Committee periodically reviews with management whether risks arising from the Company’s compensation policies and practices for all employees are reasonably likely to have a material adverse effect on the Company, as well as the means by which any potential risks may be mitigated. The Company designs the compensation programs to encourage appropriate risk-taking while discouraging behavior that may result in unnecessary or excessive business risk.
    Nominating and Corporate Governance Committee
    The Nominating and Corporate Governance Committee oversees the Board process and corporate governance-related risks, management of compliance risks, and certain ESG-related risks, including risks related to our corporate social responsibility and sustainability practices. Our Corporate Secretary provides periodic reports to the Nominating and Corporate Governance Committee on matters related to corporate governance.
    Our Board is also apprised of particular risk management matters in connection with its general oversight role, and approval of corporate matters and significant transactions. The Board does not believe that its role in the oversight of our risks affects the Board’s leadership structure.
    ANTI-HEDGING POLICY
     
    Our Board has adopted an Insider Trading Compliance Policy, which applies to all of our directors, officers and employees. The policy prohibits our directors, officers and employees and any entities they control from purchasing financial instruments such as prepaid variable forward contracts, equity swaps, collars, and exchange funds, or otherwise engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of the Company’s equity securities, or that may cause an officer, director, or employee to no longer have the same objectives as the Company’s other stockholders.
    CODE OF ETHICS
     
    We have adopted a Code of Business Conduct and Ethics that applies to all of our directors, our CEO, CFO, CAO, other officers and employees. A copy of the code is available on our website at www.talkspace.com in the “Governance” section of the “Investors” page. We expect that any amendments to the code, or any waivers of its requirements, that are required to be disclosed by SEC rules or Nasdaq Rules will be disclosed on our website.
    ATTENDANCE BY MEMBERS OF THE BOARD OF DIRECTORS AT MEETINGS
     
    There were 7 meetings of the Board during the fiscal year ended December 31, 2024. During the fiscal year ended December 31, 2024, each director attended at least 75% of the aggregate of (i) all meetings of the Board during the period in which he or she served as a director and (ii) all meetings of the committees on which the director served during the period in which he or she served as a director.
    Under our Corporate Governance Guidelines, which are available on our website at www.talkspace.com in the “Governance” section of the “Investors” page, a director is expected to spend the time and effort necessary to properly discharge his or her responsibilities. Accordingly, a director is expected to regularly prepare for and attend meetings of the Board and all committees on which the director sits (including separate meetings of the independent directors), with the understanding that, on occasion, a director may be unable to attend a meeting. A director who is unable to attend a meeting of the Board or a committee of the Board is expected to notify the Chairman of the Board or the Chairman of the appropriate committee in advance of such meeting, and, whenever possible, participate in such meeting via teleconference in the case of an in-person meeting. We do not maintain a formal policy regarding director attendance at the Annual Meeting; however, it is expected that, absent compelling circumstances, directors will attend. All of the directors serving at the time of the 2024 Annual Meeting of Stockholders attended the 2024 Annual Meeting of Stockholders.
    21

    BOARD DIVERSITY
     
    The following matrix summarizes the diversity of our Board as of April 30, 2025.
     
     
     
     
    Board Diversity Matrix as of April 30, 2025
     
     
    Total Number of Directors: 9
     
     
    Gender:
     
     
    Female
     
     
    Male
     
     
    Non-Binary
     
     
    Did not Disclose Gender
     
     
    Directors:
     
     
    4
     
     
    5
     
     
    0
     
     
    0
     
     
    Demographic Information:
     
     
    African American or Black
     
     
    0
     
     
    1
     
     
    0
     
     
    0
     
     
    Alaskan Native or Native American
     
     
    0
     
     
    0
     
     
    0
     
     
    0
     
     
    Asian
     
     
    2
     
     
    0
     
     
    0
     
     
    0
     
     
    Hispanic or Latinx
     
     
    0
     
     
    0
     
     
    0
     
     
    0
     
     
    White
     
     
    2
     
     
    4
     
     
    0
     
     
    0
     
     
    Two or more races or Ethnicities
     
     
    0
     
     
    0
     
     
    0
     
     
    0
     
     
    LGBTQ+
     
     
    1
     
     
    0
     
     
    0
     
     
    0
     
     
    Did not Disclose Demographic Background
     
     
    0
     
     
    0
     
     
    0
     
     
    0
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    COMMITTEES OF THE BOARD
     
    Our Board has established three standing committees—Audit, Compensation and Nominating and Corporate Governance—each of which operates under a written charter that has been approved by our Board.
    The members of each of the Board committees are set forth in the following chart.
     
     
     
     
     
     
     
     
     
     
    Name
     
     
    Audit
     
     
    Compensation
     
     
    Nominating
    and
    Corporate
    Governance
    Michael Hansen
     
     
    X
     
     
    X
     
     
     
    Douglas Braunstein
     
     
     
     
     
     
     
     
     
    Jon Cohen
     
     
     
     
     
     
     
     
     
    Madhu Pawar
     
     
     
     
     
     
     
     
     
    Erez Shachar
     
     
     
     
     
    Chair
     
     
    X
    Curtis Warfield
     
     
    Chair
     
     
    X
     
     
     
    Jacqueline Yeaney
     
     
    X
     
     
     
     
     
    Chair
    Swati Abbott
     
     
    X
     
     
    X
     
     
     
    Liat Ben-Zur
     
     
    X
     
     
     
     
     
    X
     
     
     
     
     
     
     
     
     
     
    AUDIT COMMITTEE
     
    Our Audit Committee’s responsibilities include, but are not limited to:
    •
    appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm;
    •
    discussing with our independent registered public accounting firm their independence;
    •
    reviewing with our independent registered public accounting firm the scope and results of their audit;
    •
    approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;
    •
    overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the SEC;
    •
    overseeing the Company’s risk management process, with the support of the Chief Compliance Officer, CTO and CISO;
    22

    •
    discussing cybersecurity-related news, updates to our cybersecurity risk management and strategy program, and any material cybersecurity risks with management;
    •
    reviewing related person transactions;
    •
    overseeing our financial and accounting controls and compliance with legal and regulatory requirements; and
    •
    establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting or auditing matters.
    The Audit Committee charter is available on our website at www.talkspace.com. The members of the Audit Committee during the fiscal year ended December 31, 2024 were Michael Hansen, Madhu Pawar, Curtis Warfield, Liat Ben-Zur, Swati Abbott, and Jacqueline Yeaney, with Curtis Warfield serving as Chair. Ms. Pawar stepped down from the Audit Committee in early 2024 upon the commencement of her services for United Healthcare. Our Board has determined that, as of December 31, 2024, each of Michael Hansen, Curtis Warfield, Swati Abbott, Liat Ben-Zur, and Jacqueline Yeaney were independent directors under Nasdaq Rules and the additional independence standards applicable to audit committee members established pursuant to Rule 10A-3 under the Exchange Act. Our board of directors has also determined that each of Michael Hansen, Curtis Warfield, Liat Ben-Zur, Swati Abbott, and Jacqueline Yeaney are able to read and understand fundamental financial statements, as required for audit committee members under the Nasdaq Stock Market Rules, and Curtis Warfield is an “audit committee financial expert” within the meaning of the SEC rules.
    The Audit Committee met 7 times during the fiscal year ended December 31, 2024.
    COMPENSATION COMMITTEE
     
    The Compensation Committee is responsible for, among other matters:
    •
    reviewing and making recommendations to the Board regarding the compensation of our chief executive and other executive officers;
    •
    reviewing and making recommendations to our Board regarding the compensation of our directors;
    •
    overseeing risks related to our compensation programs;
    •
    reviewing and approving or making recommendations to our Board regarding our incentive compensation and equity-based plans and arrangements; and
    •
    appointing and overseeing any compensation consultants.
    Pursuant to the Compensation Committee’s charter, which is available on our website at www.talkspace.com, the Compensation Committee has the authority to retain or obtain the advice of compensation consultants, legal counsel and other advisors to assist in carrying out its responsibilities. The Compensation Committee generally considers the Chief Executive Officer’s input when making recommendations regarding the compensation of non-employee directors and executive officers (other than the Chief Executive Officer). In 2024, in order to maintain a competitive executive compensation program that will continue to attract top executive talent and reflect our compensation philosophy, the Compensation Committee retained Meridian as an independent compensation consultant to provide executive compensation advisory services, help evaluate our compensation philosophy and objectives and provide guidance in designing, maintaining, and administering our executive compensation program. The Compensation Committee evaluated Meridian’s independence pursuant to the requirements of Nasdaq Rules and SEC rules and determined that Meridian does not have any conflicts of interest in advising the Compensation Committee. Meridian did not provide any other services to the Company in 2024.
    The Compensation Committee may delegate its authority under its charter to a subcommittee as it deems appropriate from time to time. The Compensation Committee has the authority to conduct or authorize investigations into any matters within the scope of its responsibilities as it deems appropriate, including the authority to request any officer, employee or adviser of the Company to meet with the Compensation Committee or any advisers engaged by the Compensation Committee. In addition to the foregoing and other authority expressly delegated to the Compensation Committee in the charter, the Compensation Committee may also exercise any other powers and carry out any other responsibilities consistent with the charter, the purposes of the Compensation Committee, the Company’s Bylaws and applicable Nasdaq Rules.
    23

    The current members of our Compensation Committee are Swati Abbott, Michael Hansen, Erez Shachar and Curtis Warfield, with Erez Shachar serving as chair. Each member of our Compensation Committee meets the requirements for independence under the current Nasdaq Rules, including the Nasdaq Rules applicable to compensation committee membership. Each of Swati Abbott, Michael Hansen, Erez Shachar and Curtis Warfield are non-employee directors, as defined in Section 16b-3 of the Exchange Act.
    The Compensation Committee met 3 times during the fiscal year ended December 31, 2024.
    NOMINATING AND CORPORATE GOVERNANCE COMMITTEE  
     
    The Nominating and Corporate Governance Committee is responsible for, among other matters:
    •
    identifying individuals qualified to become members of our Board, consistent with criteria approved by our Board, except where the Company is legally required by contract, bylaw or otherwise to provide third parties with the right to designate directors;
    •
    recommending to our Board the nominees for election to our Board at annual meetings of stockholders, except where the Company is legally required by contract, bylaw or otherwise to provide third parties with the right to designate directors;
    •
    overseeing an evaluation of the Board and its committees; and
    •
    developing and recommending to our Board a set of corporate governance guidelines and principles.
    The Nominating and Corporate Governance Committee charter is available on our website at www.talkspace.com. Our Nominating and Corporate Governance Committee consists of Liat Ben-Zur, Erez Shachar, and Jacqueline Yeaney, with Jacqueline Yeaney serving as chair. The composition of our Nominating and Corporate Governance Committee meets the requirements for independence under the Nasdaq Rules. The Nominating and Corporate Governance Committee has the authority to consult with outside advisors or retain search firms to assist in the search for qualified candidates, or consider director candidates recommended by our stockholders.
    The Nominating and Corporate Governance Committee met 3 times during the fiscal year ended December 31, 2024.
    24

    EXECUTIVE COMPENSATION
     
    COMPENSATION DISCUSSION AND ANALYSIS
    General
    In this section, we provide an overview and analysis of the compensation awarded to or earned by our named executive officers identified in the Summary Compensation Table below (each, an “NEO”) during fiscal 2024, including the elements of our compensation program for NEOs, material compensation decisions made under that program for fiscal 2024 and the material factors considered in making those decisions. In reviewing this executive compensation section, please note that we are a “smaller reporting company” as defined under applicable SEC rules and we are permitted to include scaled disclosure with respect to certain executive compensation information otherwise required by Item 402 of Regulation S-K. However, in order to give additional context regarding our executive compensation programs, we have included a more fulsome explanation of our compensation programs and philosophies where appropriate. Our NEOs for the year ended December 31, 2024 are:
    •
    Jon Cohen, our Chief Executive Officer;
    •
    Ian Harris, our Chief Financial Officer;
    •
    Jennifer Fulk, our former Chief Financial Officer;
    •
    Gil Margolin, our Chief Technology Officer;
    Executive Summary
    Compensation Governance and Best Practices
    We are committed to having strong governance standards with respect to our compensation programs, procedures and practices. Our key compensation practices include the following:
     
     
     
     
    What We Do
     
     
    What We Do Not Do
    Emphasize the use of equity compensation to promote executive retention and reward long-term value creation.
     
     
    Do not guarantee annual salary increases.
     
     
     
     
    Weight the overall pay mix towards incentive compensation for senior executives.
     
     
    Do not grant uncapped cash incentives or guaranteed equity compensation.
     
     
     
     
    Engage an independent compensation consultant to advise our Compensation Committee
     
     
    Do not provide significant perquisites.
     
     
     
     
    Maintain rigorous stock ownership guidelines and a clawback policy.
     
     
    Do not provide any compensation-related tax gross-up
     
     
     
     
    Executive Compensation Objectives and Philosophy
    The key objective in our executive compensation program is to attract, motivate, and reward leaders who create an inclusive and diverse environment and have the skills and experience necessary to successfully execute on our strategic plan to maximize stockholder value. Our executive compensation program is designed to:
    •
    Attract and retain talented and experienced executives in a competitive and dynamic market;
    •
    Motivate our NEOs to help our company achieve the best possible financial and operational results;
    •
    Provide reward opportunities consistent with our performance on both a short-term and long-term basis that are industry-competitive, flexible, fiscally responsible, and linked to our overall business objectives; and
    •
    Align the long-term interests of our NEOs with those of our stockholders.
    We strive to set our overall total compensation at a competitive level. Executives may be compensated above or below the targeted market position based on factors such as experience, performance, scope of position and the competitive demand for proven executive talent, as described further below under “Determination of Executive Compensation.”
    25

    Determination of Executive Compensation
    Role of Board of Directors, the Compensation Committee, and Executive Officers
    The Compensation Committee is responsible for establishing and overseeing our executive compensation programs and will annually review and recommend to the Board for approval the compensation to be provided to our executive officers.
    In setting executive compensation, the Compensation Committee will consider a number of factors, including the recommendations of our Chief Executive Officer (other than with respect to the Chief Executive Officer’s own compensation) and our human resources team, current and past total compensation, competitive market data and analysis provided by the Compensation Committee’s independent compensation consultant, Company performance and each executive’s impact on performance, each executive’s relative scope of responsibility and potential, each executive’s individual performance and demonstrated leadership, and internal equity pay considerations. Our Chief Executive Officer’s recommendations are based on his evaluation of each other executive officer’s individual performance and contributions, of which our Chief Executive Officer has direct knowledge. Decisions with respect to our Chief Executive Officer’s compensation are made without the presence of management. Our Board makes decisions regarding our Chief Executive Officer’s and other executive officers’ compensation, following recommendations from the Compensation Committee.
    Role of Compensation Consultant
    In order to design a competitive executive compensation program that will continue to attract top executive talent and reflect our compensation philosophy, our Compensation Committee has retained Meridian as an independent compensation consultant to provide executive compensation advisory services, help evaluate our compensation philosophy and objectives and provide guidance in designing, maintaining, and administering our executive compensation program. The Compensation Committee has evaluated Meridian’s independence pursuant to the requirements of Nasdaq Rules and SEC rules and has determined that Meridian does not have any conflicts of interest in advising the Compensation Committee. Meridian did not provide any other services to the Company in 2024.
    Our Compensation Committee may also refer to compensation survey data when making decisions related to our compensation programs.
    Elements of Compensation
    The primary elements of our NEOs’ compensation and the main objectives of each are:
    •
    Base Salary. Base salary attracts and retains talented executives, recognizes individual roles and responsibilities, and provides compensation in respect of an executive’s day-to-day responsibilities;
    •
    Annual Cash Incentive Compensation. Annual bonuses promote short-term performance objectives and reward executives for their contributions to Company performance;
    •
    Equity Based Long-Term Incentive Compensation. Equity compensation, provided in the form of stock options and RSUs during 2024, aligns executives’ interests with our stockholders’ interests, emphasizes long-term financial and operational performance, and helps retain executive talent.
    In addition, our NEOs are eligible to participate in our health and welfare programs and our 401(k) plan on the same basis as our other employees. We also maintain severance and change in control arrangements, which aid in attracting and retaining executive talent and help executives to remain focused and dedicated during potential transition periods due to a change in control. Each of these elements of compensation for 2024 is described further below.
    26

    Base Salary
    The base salaries of our NEOs are an important part of their total compensation package, and are intended to reflect their respective positions, duties and responsibilities. Base salaries provide our NEOs with a reasonable degree of financial certainty and stability. Our Compensation Committee intends to annually review and determine the base salaries of our executives and evaluate the base salaries of new hires at the time of hire. Our NEOs’ base salaries as of December 31, 2024 are set forth below:
     
     
     
     
    Name
     
     
    2024 Annualized Base
    Salary at Year-End
    Jon Cohen
     
     
    $600,000
    Jennifer Fulk(1)
     
     
    $400,000
    Ian Harris(2)
     
     
    $400,000
    Gil Margolin
     
     
    $400,000
     
     
     
     
    (1)
    The Company previously announced that Ms. Fulk would no longer serve as the Company’s Chief Financial Officer effective as of May 20, 2024. In connection therewith, the Company entered into a separation agreement with Ms. Fulk (the “Separation Agreement”). Pursuant to the terms of the Separation Agreement, Ms. Fulk received a severance payment equal to $400,000, representing her current annual base salary, to be paid over 12 months.
    (2)
    Due to his start date of May 20, 2024, Mr. Harris was actually paid $247,000 of his annualized base salary of $400,000.
    Cash Incentive Compensation
    We consider annual cash incentive bonuses to be an important component of our total compensation program, providing incentives necessary to retain executive officers. Each NEO is eligible to receive an annual performance-based cash bonus based on a specified target annual bonus award amount, expressed as a percentage of the NEO’s base salary. As of December 31, 2024, target bonuses were as follows:
     
     
     
     
    Named Executive Officer
     
     
    Target Percentage
    (as a Percentage
    of Base Salary)(3)
    Jon Cohen
     
     
    100%
    Jennifer Fulk(1)
     
     
    100%
    Ian Harris(2)
     
     
    100%
    Gil Margolin
     
     
    100%
     
     
     
     
    (1)
    Pursuant to the terms of her Separation Agreement, the Company agreed to honor Ms. Fulk’s 2024 bonus at 50% of the total amount awarded (at least 100% of personal amount and up to 150% of the Company amount) with the caveat that in no event would it be less than $200,000.
    (2)
    Pursuant to the terms of his Offer Letter, Mr. Harris’ 2024 bonus was pro-rated to account for his May 2024 hire date to 7/12ths of his target Annual Bonus, which going forward will be equal to 100% of his base annual salary.
    Under the 2024 annual bonus program, each NEO was eligible to receive a percentage of the NEO’s target bonus opportunity, ranging from 0% to 150%, as determined by our Chief Executive Officer (other than with respect to his own compensation and as footnoted in the table above) and the Board in their discretion based upon individual and Company performance in 2024. Each NEO who was eligible for a 2024 annual bonus, was ultimately awarded an annual bonus at 82% of target. In making this determination, the Board (and, other than with respect to his own compensation, our Chief Executive Officer) considered various indicators of Company and individual performance.
    The NEOs’ 2024 performance bonuses are set forth in the column entitled “Bonus” in the “Summary Compensation Table” below.
    Equity-Based Long-Term Incentive Awards
    We view equity-based compensation as a critical component of our balanced total compensation program. Equity-based compensation creates an ownership culture among our employees that provides an incentive to contribute to the continued growth and development of our business and aligns the interest of executives with those of our stockholders. We believe it is essential to provide equity-based compensation to our executive officers in order to link the interests and risks of our executive officers with those of our stockholders, reinforcing our commitment to ensuring a strong linkage between company performance and pay.
    27

    In 2024, we maintained the 2014 Stock Incentive Plan (the “2014 Plan”), which was implemented prior to the closing of the Business Combination. Under the 2014 Plan, we offered awards of stock options to eligible service providers, including our NEOs who were employed by us prior to the Business Combination (i.e., Mr. Reilly and Mr. Margolin). In connection with the closing of the Business Combination and the adoption of the 2021 Incentive Award Plan (the “2021 Plan”), no further awards have been granted under the 2014 Plan; however, any outstanding awards granted under the 2014 Plan will remain outstanding, subject to the terms of the 2014 Plan and any applicable award agreement. Options granted prior to the Business Combination generally vest over four years in 48 equal monthly installments and awards granted following the Business Combination generally vest over four years in 16 equal quarterly installments, in each case subject to continued service; however, new employee grants (both prior to and following the Business Combination) are generally subject to one year of cliff vesting followed by equal monthly or quarterly installments thereafter, as applicable.
    In 2024, we granted equity-based compensation under the 2021 Plan to our NEOs in the form of the following grants of stock options and RSUs:
     
     
     
     
     
     
     
    Name
     
     
    Number of Shares
    Underlying Stock
    Options(1)
     
     
    Number of RSUs(2)
    Jon Cohen
     
     
    214,051
     
     
    128,866
    Jennifer Fulk
     
     
    74,205(3)
     
     
    178,695(4)
    Ian Harris
     
     
    0
     
     
    311,250(5)
    Gil Margolin
     
     
    27,399
     
     
    65,980
     
     
     
     
     
     
     
    (1)
    The stock options vest in 16 substantially equal installments on a quarterly basis, subject to the NEO’s continued service with the Company through each vesting date.
    (2)
    The RSUs vest in 16 substantially equal installments on a quarterly basis, subject to the NEO’s continued service with the Company through each vesting date.
    (3)
    All the stock options granted to Ms. Fulk were forfeited in connection with her separation from the Company and pursuant to the terms of her Separation Agreement.
    (4)
    89,347 of the RSUs granted to Ms. Fulk were forfeited in connection with her separation from the Company and pursuant to the terms of her Separation Agreement.
    (5)
    Prior to his appointment as the Company's Chief Financial Officer, Mr. Harris was engaged by the Company in early 2024 as an independent consultant and pursuant to the terms of his Consulting Services Agreement, was awarded 11,250 RSUs as consideration for his consulting services. Upon the early termination of his Consulting Services Agreement and his appointment as the Company's Chief Financial Officer on May 20, 2024, 6,250 unvested RSUs were forfeited.
    Both the option grants and the RSU grants were intended to retain our NEOs and incentivize them to lead our company to sustained, long-term superior financial and operational performance and were approved following consideration of the factors set forth above under “Determination of Executive Compensation”.
    Retirement Savings, Health and Welfare Benefits
    We maintain a 401(k) retirement savings plan for our employees, including our NEOs, who satisfy certain eligibility requirements. Our NEOs are eligible to participate in the 401(k) plan on the same terms as other full-time employees. Currently, we match contributions made by participants in the 401(k) plan up to a specified percentage of the employee contributions, and these matching contributions are fully-vested as of the date on which the contribution is made. We believe that providing a vehicle for tax-deferred retirement savings though our 401(k) plan, and making fully vested matching contributions, adds to the overall desirability of our executive compensation package and further incentivizes our employees, including our NEOs, in accordance with our compensation policies.
    Employee Benefits and Perquisites
    All of our full-time employees, including our NEOs, are eligible to participate in our health and welfare plans, including medical, dental and vision benefits, medical and dependent care flexible spending accounts, short-term and long-term disability insurance, and life insurance. We believe the benefits described above are necessary and appropriate to provide a competitive compensation package to our NEOs.
    We do not currently provide perquisites to our NEOs, and we do not view perquisites or other personal benefits as a significant component of our executive compensation program. In the future, we may provide perquisites or other personal benefits in limited circumstances, such as where we believe it is appropriate to assist an individual executive
    28

    officer in the performance of the executive’s duties, to make our executive officers more efficient and effective, and/or recruitment, motivation, or retention purposes. All future practices with respect to perquisites or other personal benefits will be approved by the Compensation Committee.
    We do not generally provide any tax “gross-ups” to our NEOs.
    Severance and Change in Control Arrangements
    The Executive Severance Plan (as amended and restated, the “Executive Severance Plan”), which provides certain of our executives, including our NEOs, with severance benefits and payments upon certain terminations without cause or, following a change in control, resignations for good reason. Our Compensation Committee believes that the Executive Severance Plan is necessary to attract and retain executive talent and is a customary component of executive compensation. In particular, the Executive Severance Plan can mitigate a potential disincentive for our NEOs when they are evaluating a potential acquisition of the Company and can encourage retention through the conclusion of the transaction. The payments and benefits provided under the Executive Severance Plan are designed to be competitive with market practices. A description of the Executive Severance Plan, as well as information on the estimated payments and benefits that our NEOs would have been eligible to receive as of December 31, 2024, is set forth in “Potential Payments Upon Termination or Change in Control” below.
    Other Policies and Considerations
    Clawback Policy. We believe in maintaining best practices for our executive compensation program. Consistent with that belief, our board of directors has adopted a “clawback” policy, intended to comply with the listing requirements of NASDAQ, with respect to excess incentive-based cash and equity compensation in the event our publicly disclosed financial statements are required to be restated (as either a “big R” or “little R” restatement) due to material noncompliance with any financial reporting requirement. If such a restatement were to occur, the policy would require the Compensation Committee to recover cash incentives, equity awards or other incentive compensation of employees to the extent such compensation would have been reduced if calculated under the restatement, regardless of whether the employee was responsible for the restatement. This clawback policy only applies to incentive-based compensation that vests in whole or in part based on financial performance measures or stock price measures. Additionally, the policy provides the Compensation Committee with the discretion to recover cash incentives, equity awards or other incentive compensation of employees who have engaged in behavior that is intentionally contrary to or in reckless disregard of the employee’s duties to the Company or in material violation of the Company’s code of conduct, any other Company policy, or any law or regulation.
    Stock Ownership Guidelines. Effective June 22, 2021, the Board adopted stock ownership guidelines that are applicable to our executive officers, including our NEOs, and to our non-employee directors. Our executive officers and non-employee directors are expected to satisfy the applicable guidelines based on a base salary or annual retainer multiple, as applicable, within five years of the later of (i) the effective date of the guidelines, and (ii) the date of such individual’s appointment to a position with the Company that is subject to such guidelines, and to hold at least the applicable minimum value in shares of common stock for so long as they are an executive officer or non-employee director, as applicable. We believe that stock ownership guidelines align the interests of our officers and directors with those of our stockholders and encourage long-term management of the Company for the benefit of its stockholders.
    Anti-Hedging Policy. Our Board of Directors has adopted an Insider Trading Compliance Policy, which applies to all of our directors, officers, and employees. The policy prohibits our directors, officers, and employees and any entities they control from purchasing financial instruments, such as prepaid variable forward contracts, equity swaps, collars, and exchange funds, or otherwise engaging in transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of the Company’s equity securities.
    Insider Trading Compliance Policy. We have adopted insider trading policies and procedures applicable to our directors, officers, employees, and other covered persons, and have implemented processes for the company, that we believe are reasonably designed to promote compliance with insider trading laws, rules and regulations, and the Nasdaq Stock Market LLC listing standards. Our Insider Trading Compliance Policy provides that no officer, director or employee or any entities they control may purchase, acquire or sell (or contract to purchase, acquire or sell) any type of security while in possession of material, non-public information relating to the security or the issuer of the security (whether or not the issuer of the security is the Company). This includes a put option, a call option or a short sale, or engaging in hedging transactions, as further described above under “Anti-Hedging Policy”. In addition, the prohibitions under our Insider Trading Compliance Policy do not apply to certain transactions, such as the exercise
    29

    of stock options and/or the surrender of shares to the Company in payment of the exercise price or in satisfaction of any tax withholding obligations, pursuant to the applicable equity incentive plan or award agreement; such exceptions are only permitted to the extent they do not involve a market sale of the Company’s securities.
    Accounting for Share-Based Compensation. We follow Financial Accounting Standards Board Accounting Standards Codification Topic 718, (“ASC Topic 718”) for our share-based compensation awards. ASC Topic 718 requires companies to measure the compensation expense for all share-based payment awards made to employees and directors, including stock options and RSUs, based on the grant-date “fair value” of these awards. This calculation is performed for accounting purposes and reported in the compensation tables below, even though our NEOs may never realize any value from their awards.
    Equity Grant Processes and Timing. The Compensation Committee does not grant equity awards in anticipation of the release of material nonpublic information (“MNPI”), and the Company does not time the release of MNPI based upon grant dates of equity. Most grants equity awards to our executive officers, including our NEOs, are made annually on March 1, and such awards are recommended by the Compensation Committee at its regularly scheduled first quarter meeting. Equity awards made to executive officers, including each of our NEOs, are approved by the Compensation Committee. For annual equity awards made to other employees, the Compensation Committee approves a budget for equity awards made under the 2021 Plan for the fiscal year, and such awards are issued on the first day of the last month of each quarter based on recommendations from our management team. In the event MNPI becomes known to the Compensation Committee before granting an equity award, the Compensation Committee will consider such information and use its business judgment to determine whether to delay the grant of equity to avoid any appearance of impropriety. The Company did not grant equity awards to any NEO during any period beginning four business days before and ending one business day after the filing of any Company periodic report on Form 10-Q or Form 10-K, or the filing or furnishing of any Company current report on Form 8-K that disclosed any MNPI during fiscal 2024.
    30

    EXECUTIVE COMPENSATION TABLES
    Summary Compensation Table
    The following table contains information about the compensation earned by each of our NEOs during fiscal years ended December 31, 2024 and December 31, 2023.
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Name
     
     
    Principal Position
     
     
    Year
     
     
    Salary
    ($)
     
     
    Bonus
    ($)(1)
     
     
    Stock Awards
    ($)(2)
     
     
    Option
    Awards
    ($)(2)
     
     
    All Other
    Compensation
    ($)(3)
     
     
    Total
    ($)
    Jon Cohen
     
     
    Chief Executive
    Officer
     
     
    2024
     
     
    600,000
     
     
    494,400
     
     
    385,309
     
     
    389,059
     
     
    24,289
     
     
    1,893,057
     
    2023
     
     
    600,000
     
     
    715,200
     
     
    —
     
     
    —
     
     
    22,123
     
     
    1,337,323
    Ian Harris
     
     
    Chief Financial
    Officer
     
     
    2024
     
     
    233,000
     
     
    219,733
     
     
    ​800,950
     
     
    0
     
     
    ​30,598
     
     
    ​1,281,423
     
    2023
     
     
    —
     
     
    —
     
     
    —
     
     
    —
     
     
    —
     
     
    —
    Jennifer Fulk
     
     
    Former Chief
    Financial Officer
     
     
    2024
     
     
    153,000
     
     
    200,000
     
     
    ​1,008,958
     
     
    ​37,779
     
     
    ​430,744(4)
     
     
    ​1,830,481
     
    2023
     
     
    400,000
     
     
    476,800
     
     
    378,420
     
     
    86,879
     
     
    31,005
     
     
    1,373,104
    Gil Margolin(4)
     
     
    Chief Technology
    Officer
     
     
    2024
     
     
    400,000
     
     
    329,600
     
     
    197,280
     
     
    ​49,801
     
     
    31,100
     
     
    ​1,007,781
     
    2023
     
     
    400,000
     
     
    476,800
     
     
    139,725
     
     
    32,079
     
     
    30,704
     
     
    1,079,308
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    (1)
    2024 amounts represent discretionary annual bonus which were paid in February 2025. 2023 amounts represent discretionary annual bonus which was paid in February 2024.
    (2)
    Amounts reflect the full grant-date fair value of restricted stock units and stock options granted during fiscal 2024 and 2023computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of all restricted stock units and option awards made to our NEOs in Note 2 and Note 10 to the consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.
    (3)
    Amounts represent matching contributions received under the Company’s 401(k) plan, the employer paid portion of medical premiums, life and accidental insurance and, short-term and long-term disability insurance.
    (4)
    This amount includes separation payments in the amount of $400,000 in salary payments and $9,744 in COBRA payments paid to Ms. Fulk pursuant to the terms of her Separation Agreement.
    NARRATIVE TO SUMMARY COMPENSATION TABLE
    Summary of Executive Compensation Arrangements
    Named Executive Officer Employment Agreements
    We have entered into employment offer letters (collectively, the “Employment Agreements”) with each of our NEOs. The material terms of the Employment Agreements are described below.
    The Employment Agreements provide for at-will employment without a specified term, provide for participation in the health and welfare benefit plans and programs maintained by us for the benefit of our employees, and provide for annual base salaries and annual target bonus percentages.
    In addition, the Employment Agreements provide for option and RSU grants under the 2021 Plan in the amounts and subject to the vesting conditions and contain customary confidentiality and assignment of invention provisions, as well as standard non-compete and non-solicit restrictions effective during employment and for 12 months thereafter.
    31

    Outstanding Equity Awards at Fiscal Year-End Table
    The following table summarizes the number of shares of common stock underlying outstanding equity incentive plan awards for each NEO as of December 31, 2024.
     
     
     
     
     
     
     
     
     
     
    Name
     
     
    Grant Date
     
     
    Option Awards
     
     
    Stock Awards
     
    Number of
    Securities
    Underlying
    Unexercised
    Options
    (#)
    Exercisable
     
     
    Number of
    Securities
    Underlying
    Unexercised
    Options
    (#)
    Unexercisable
     
     
    Option
    Exercise
    Price
    ($)
     
     
    Option
    Expiration
    Date
     
     
    Number of
    Shares or
    Units of
    Stock That
    Have Not
    Vested
    (#)
     
     
    Market
    Value of
    Shares or
    Units of
    Stock That
    Have Not
    Vested
    ($)(1)
    Jon Cohen
     
     
    9/26/2022(2)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    39,383
     
     
    $121,693
     
     
     
    9/26/2022(3)
     
     
    100,105
     
     
    100,106
     
     
    1.00
     
     
    9/24/2032
     
     
     
     
     
     
     
     
     
    12/1/2022(4)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    1,437,500
     
     
    $4,441,875
     
     
     
    12/1/2022(5)
     
     
    325,000
     
     
    575,000
     
     
    0.86
     
     
    11/30/2032
     
     
     
     
     
     
     
     
     
    3/1/2024 (6)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    104,704
     
     
    $323,535
     
     
     
    3/1/2024(7)
     
     
    40,134
     
     
    173,917
     
     
    2.99
     
     
    3/1/2034
     
     
     
     
     
     
    Ian Harris
     
     
    6/1/2024(8)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    300,000
     
     
    $927,000
    Jennifer Fulk
     
     
    7/15/2021(9)
     
     
    338,662
     
     
    —
     
     
    5.81
     
     
    3/30/2025
     
     
     
     
     
     
     
     
     
    3/1/2022(9)
     
     
    61,699
     
     
    —
     
     
    1.61
     
     
    3/30/2025
     
     
     
     
     
     
     
     
     
    3/1/2023(9)
     
     
    38,092
     
     
    —
     
     
    0.88
     
     
    3/30/2025
     
     
     
     
     
     
    Gil Margolin
     
     
    7/15/2021(10)
     
     
    402,187
     
     
    92,813
     
     
    5.81
     
     
    7/14/2031
     
     
     
     
     
     
     
     
     
    10/18/2021(11)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    23,204
     
     
    $71,700
     
     
     
    3/1/2022(12)
     
     
    2,849
     
     
    14,239
     
     
    1.61
     
     
    2/28/2032
     
     
     
     
     
     
     
     
     
    3/1/2022(13)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    39,736
     
     
    $122,784
     
     
     
    3/1/2023(14)
     
     
    —
     
     
    31,647
     
     
    0.88
     
     
    2/28/2033
     
     
     
     
     
     
     
     
     
    3/1/2023(15)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    89,619
     
     
    $276,923
     
     
     
    3/1/2024(7)
     
     
    5,136
     
     
    22,263
     
     
    2.99
     
     
    3/1/2034
     
     
     
     
     
     
     
     
     
    3/1/2024(6)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    53,609
     
     
    $165,652
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    (1)
    Amounts are calculated based on multiplying the number of shares shown in the table by the per share closing price of our common stock on December 31, 2024, which was $3.09.
    (2)
    These RSU awards, which were granted under the 2021 Plan, vest over a four-year period on each anniversary of June 22, 2022, subject to the NEO’s continued employment through each such vesting date.
    (3)
    These stock options, which were granted under the 2021 Plan, vest and become exercisable in four equal installments on each anniversary of June 22, 2022, subject to the NEO’s continued employment through each such vesting date.
    (4)
    1,250,000 RSU awards, which were granted under the 2021 Plan, vest 25% on the one-year anniversary of December 1, 2022 and 75% in twelve equal installments on each of the first twelve quarterly anniversaries of December 1, 2023 thereafter, subject to the NEO’s continued employment through each such vesting date. 1,000,000 RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2024, subject to the NEO’s continued employment through each such vesting date.
    (5)
    500,000 stock options, which were granted under the 2021 Plan, vest and became exercisable 25% on the one-year anniversary of December 1, 2022 and 75% in twelve equal installments on each of the first twelve quarterly anniversaries of December 1, 2023 thereafter, subject to the NEO’s continued employment through each such vesting date. 400,000 stock options, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2024, subject to the NEO’s continued employment through each such vesting date.
    (6)
    These RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2024, subject to the NEO’s continued employment through each such vesting date.
    (7)
    These stock options, which were granted under the 2021 Plan, vest and become exercisable in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2024 thereafter, subject to the NEO’s continued employment through each such vesting date.
    (8)
    These RSU awards, which were granted under the 2021 Plan, vest over a four-year period on each anniversary of June 1, 2024, subject to the NEO’s continued employment through each such vesting date.
    (9)
    These stock options, which were granted under the 2021 Plan are fully vested as part of Jennifer Fulk's separation agreement
    (10)
    These stock options, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of July 1, 2021, subject to the NEO’s continued employment through each such vesting date.
    (11)
    These RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of September 1, 2021, subject to the NEO’s continued employment through each such vesting date.
    (12)
    These stock options, which were granted under the 2021 Plan, vest and become exercisable in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2022 thereafter, subject to the NEO’s continued employment through each such vesting date.
    32

    (13)
    These RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2022 thereafter, subject to the NEO’s continued employment through each such vesting date.
    (14)
    These stock options, which were granted under the 2021 Plan, vest and become exercisable in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2023 thereafter, subject to the NEO’s continued employment through each such vesting date.
    (15)
    These RSU awards, which were granted under the 2021 Plan, vest in sixteen equal installments on each of the first sixteen quarterly anniversaries of March 1, 2023 thereafter, subject to the NEO’s continued employment through each such vesting date.
    Potential Payments Upon Termination or Change in Control
    Executive Severance Plan
    All of our NEOs are participants in the Executive Severance Plan, which provides for payments and benefits upon a participant’s termination without cause or resignation with good reason. The Executive Severance Plan is administered by our Compensation Committee.
    Participants in the Executive Severance Plan are designated as either Tier 1 or Tier 2 participants at the time they are selected to participate. Currently, Messrs. Cohen, Harris and Margolin are Tier 1 participants.
    Pursuant to the terms of the Executive Severance Plan, in the event a participant is terminated without “cause” or resigns for “good reason” (each, as defined in the Executive Severance Plan), in each case, other than on or within the period beginning three months prior to a change in control and ending 12 months following a change in control, the participant will be eligible to receive: (i) salary continuation for 12 months, in the case of Tier 1 participants, or 6 months, in the case of Tier 2 participants; and (ii) payment or reimbursement of COBRA premiums for up to 12 months, in the case of Tier 1 participants, or 6 months, in the case of Tier 2 participants.
    In the event a participant in the Executive Severance Plan is terminated without “cause” or resigns for “good reason”, in each case, on or within the period beginning 3 months prior to a change in control and ending 12 months following a change in control, the participant will be eligible to receive: (i) salary continuation for 24 months plus 200% of the participant’s target bonus amount, in the case of a Tier 1 participant, or salary continuation for 12 months plus 100% of the participant’s target bonus amount, in the case of a Tier 2 participant; (ii) a lump sum cash payment equal to the participant’s pro-rata target bonus amount; (iii) payment or reimbursement of COBRA premiums for up to 18 months, in the case of a Tier 1 participant, or 12 months, in the case of a Tier 2 participant; and (iii) full accelerated vesting of all equity awards.
    All severance payments and benefits under the Executive Severance Plan are subject to the participant’s execution of a release of claims against us and continued compliance with certain restrictive covenants. The Executive Severance Plan also includes a Section 280G “best pay” provision, which provides that if any amount received by a participant pursuant to the Executive Severance Plan that would be subject to the excise tax imposed by Section 4999 of the Code, the participant would receive the full amount of the payments and benefits or an amount reduced so that no portion would be subject to the excise tax, whichever would result in the largest payment to the participant on an after-tax basis.
    Equity Plans
    Certain stock options granted under the 2014 Plan in August 2019 to Mr. Margolin and Mr. Reilly and in August 2020 to Mr. Margolin originally provided for 25% of the option to vest and become exercisable upon the executive’s termination without cause, or if the Company completed a deemed liquidation event or an initial public offering of its common stock. These options also originally provided that they would vest and become exercisable in full upon the executive’s termination without cause within 12 months following (i) a deemed liquidation event or (ii) an initial public offering of the Company’s common stock. In connection with the Business Combination, the Company entered into a waiver agreement with each of the named executive officers under which each named executive officer waived his right to the 25% accelerated vesting upon a deemed liquidation event. Under 2021 Plan, in the event of a change in control where any outstanding awards under the 2021 Plan are not substituted or assumed, such awards will become fully vested, exercisable, and/or payable in connection with the change in control.
    The award agreements applicable to RSUs and stock options under the 2021 Plan generally provide that in the event of any termination of employment, all RSUs and stock options that are unvested would be forfeited; provided, that, in the event of death or disability that occurs on or after the first anniversary of the participant’s employment start date, all RSUs and stock options that are unvested would accelerate vesting. Pursuant to the terms of Mr. Cohen’s offer letter, in the event he experiences a qualifying termination under the Severance Plan following the first anniversary of his start date, he will vest in a number of RSUs and stock options underlying the initial grant he
    33

    received in December of 2022 that he would have otherwise vested in had he remained employed by the Company for the 12-month period immediately following his termination date, subject to his compliance with all other terms and conditions of the Severance Plan and his offer letter.
    Estimated Potential Payments
    The following table summarizes the payments that would be made to our NEOs upon the occurrence of certain qualifying terminations of employment or a change in control, in any case, occurring on December 31, 2024. Amounts shown do not include (i) accrued but unpaid base salary through the date of termination or (ii) other benefits earned or accrued by the NEO during his or her employment that are available to all salaried employees, such as accrued vacation and the annual incentive bonus earned in respect of 2024.
     
     
     
     
     
     
     
     
     
     
     
     
     
    Name
     
     
    Benefit
     
     
    Termination Without
    Cause or for Good
    Reason / Cause
    (no Change in Control)
    ($)
     
     
    Change in Control
    (no Termination)
    ($)(1)
     
     
    Termination Without
    Cause or for Good
    Reason / Cause
    in Connection with a
    Change in Control
    ($)
    Jon Cohen
     
     
    Cash
     
     
    600,000
     
     
    —
     
     
    2,400,000
     
     
     
    Equity Acceleration
     
     
    —
     
     
    —
     
     
    6,395,966(2)
     
     
     
    Continued Healthcare
     
     
    47,002
     
     
    —
     
     
    70,503
     
     
     
    Total(3)
     
     
    647,002
     
     
    —
     
     
    8,866,469
    Ian Harris
     
     
    Cash
     
     
    400,000
     
     
    —
     
     
    1,600,000
     
     
     
    Equity Acceleration
     
     
    —
     
     
    —
     
     
    927,000(2)
     
     
     
    Continued Healthcare
     
     
    47,002
     
     
    —
     
     
    70,503
     
     
     
    Total(3)
     
     
    447,002
     
     
    —
     
     
    2,597,503
    Jennifer Fulk
     
     
    Cash
     
     
    600,000
     
     
    —
     
     
    —
     
     
     
    Equity Acceleration
     
     
    1,046,737
     
     
    —
     
     
    —
     
     
     
    Continued Healthcare
     
     
    9,744
     
     
    —
     
     
    —
     
     
     
    Total(3)
     
     
    1,656,481
     
     
    —
     
     
    —
    Gil Margolin
     
     
    Cash
     
     
    400,000
     
     
    —
     
     
    1,600,000
     
     
     
    Equity Acceleration
     
     
    —
     
     
    —
     
     
    730,299(2)
     
     
     
    Continued Healthcare
     
     
    47,002
     
     
    —
     
     
    70,503
     
     
     
    Total(3)
     
     
    447,002
     
     
    —
     
     
    2,400,802
     
     
     
     
     
     
     
     
     
     
     
     
     
    (1)
    Pursuant to the 2021 Plan and the applicable award agreements, in the event of a change in control where an acquiror assumes, replaces or substitutes outstanding equity awards, awards under the 2021 Plan would not accelerate vesting. For purposes of the table above, we have assumed that awards are assumed, replaced or substituted in connection with the change in control.
    (2)
    Assumes full acceleration of all unvested equity awards outstanding as of December 31, 2024. With respect to options, the value of equity acceleration was calculated by (i) multiplying the number of accelerated shares of common stock underlying the options by $2.54, the closing trading price of our common stock on December 29, 2023 and (ii) subtracting the exercise price for the options. No value is shown in respect of accelerated option shares with an exercise price that exceeds $2.54. With respect to RSUs, the value of equity acceleration was calculated by multiplying the number of accelerated RSUs by $2.54, the closing trading price of our common stock on December 29, 2023.
    (3)
    Amounts shown are the maximum potential payment the NEO would have received as of December 31, 2024. The amounts of any reduction pursuant to the 280G best pay provision, if any, would be calculated upon actual termination of employment.
    (4)
    Pursuant to the terms of Dr. Cohen’s offer letter, in the event he experiences a qualifying termination under the Severance Plan following the first anniversary of his start date, he will vest in a number of RSUs and stock options underlying the initial grant he received in December of 2022 that he would have otherwise vested in had he remained employed by the Company for the 12-month period immediately following his termination date, subject to his compliance with all other terms and conditions of the Severance Plan and his offer letter.
    34

    Pay versus Performance
     
    We are permitted to report as a “smaller reporting company” as defined under the U.S. federal securities laws. Accordingly, we have not included a tabular list of financial performance measures, and the table below does not include a column for either the value of initial $100 investment based on peer group total shareholder return or a company-selected measure, as provided in Item 402(v) of Regulation S-K.
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Year
     
     
    Summary
    Compensation
    Table Total
    for PEO ($)(1)
     
     
    Compensation
    Actually paid
    to PEO ($)(2)
     
     
    Average
    Summary
    Compensation
    Table Total
    for Non-PEO
    Named
    Executive
    Officers ($)(3)
     
     
    Average
    Compensation
    Actually Paid
    to Non-PEO
    Named Executive
    Officers ($)(4)
     
     
    Value of Initial
    Fixed $100
    investment
    based on Total
    Shareholder
    Return ($)(5)
     
     
    Net Income
    (Loss) in
    Thousands ($)(6)
    (a)
     
     
    (b)
     
     
    (c)
     
     
    (b)
     
     
    (c)
     
     
    (d)
     
     
    (e)
     
     
    (f)
     
     
    (g)
    2024
     
     
    1,893,057
     
     
    —
     
     
    3,128,158
     
     
    —
     
     
    1,378,848
     
     
    838,499
     
     
    122
     
     
    1,148
    2023
     
     
    1,337,323
     
     
    —
     
     
    7,339,634
     
     
    —
     
     
    1,226,206
     
     
    2,563,612
     
     
    416
     
     
    (19,182)
    2022
     
     
    2,747,622
     
     
    2,721,615
     
     
    1,901,408
     
     
    2,638,837
     
     
    1,412,753
     
     
    756,180
     
     
    31
     
     
    (79,672)
    (1)
    The dollar amounts reported in column (b) are the amounts of Total compensation reported for Mr. Cohen for 2024 in the Summary Compensation Table. The dollar amounts reported in column (b) for 2023 are the amounts of Total compensation reported for Mr. Cohen for 2023 in the Summary Compensation table. The dollar amounts reported in column (b) for 2022 are the amounts of Total compensation reported for Mr. Cohen for 2022 in the Summary Compensation Table. Mr. Cohen was appointed as Chief Executive Officer on November 9, 2022. The dollar amounts reported in column (c) for 2022 are the amounts of Total compensation reported for Mr. Braunstein for 2022 in the Summary Compensation Table. During 2022, Mr. Braunstein served as Interim Chief Executive Officer until November 8, 2022.
    (2)
    The dollar amounts reported in columns (b) for 2023 represent the amount of “compensation actually paid” to Mr. Cohen for 2024. The dollar amounts reported in columns (b) for 2023 represent the amount of “compensation actually paid” to Mr. Cohen. The dollar amounts reported in columns (b) and (c) 2022 represent the amount of “compensation actually paid” to Mr. Cohen and Mr. Braunstein and, respectively, as computed in accordance with Item 402(v) of Regulation S-K for such year. The dollar amounts do not reflect the actual amount of compensation earned by or paid to these executives during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to total compensation for 2024 to determine the compensation actually paid to Mr. Cohen for 2023:
     
     
     
     
     
     
     
     
     
     
     
     
     
    Year
     
     
    Reported Summary
    Compensation Table
    Total for PEO 1
    (Mr. Cohen)
     
     
    Deduct Reported
    Value of Equity Awards
     
     
    Equity Award
    Adjustments(a)
     
     
    Compensation
    Actually Paid to PEO 1
    (Mr. Cohen)
    2024
     
     
    $1,893,057
     
     
    $(774,368)
     
     
    $2,009,469
     
     
    $3,128,158
     
     
     
     
     
     
     
     
     
     
     
     
     
    (a)
    The amounts deducted or added in calculating the total average equity award adjustments are as follows:
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Year
    (PEO 1)
     
     
    Year End Fair
    Value of Equity
    Awards
    Outstanding and
    Unvested Granted
    in the Year
     
     
    Year over
    Year Change
    in Fair Value
    of
    Outstanding
    and Unvested
    Equity
    Awards
    Granted in
    Prior years
     
     
    Fair Value as
    of Vesting
    Date of
    Equity
    Awards
    Granted and
    Vested in the
    Year
     
     
    Change in
    Fair Value
    as of
    Vesting Date
    of Equity
    Awards
    Granted in
    Prior Years
    that Vested
    in the Year
     
     
    Fair Value
    at the End of
    the Prior
    Year of
    Equity
    Awards that
    Failed to
    Meet
    Vesting
    Conditions
    in the Year
     
     
    Value of
    Dividends or
    other
    Earnings Paid
    on Stock or
    Option
    Awards not
    Otherwise
    Reflected in
    Fair Value or
    Total
    Compensation
     
     
    Total
    Equity
    Award
    Adjustments
    2024
     
     
    $648,585
     
     
    $1,085,436
     
     
    $127,506
     
     
    $147,942
     
     
    $0
     
     
    $0
     
     
    $2,009,469
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    (3)
    The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s non-CEO named executive officers (NEOs) as a group in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the non-CEO NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2023, Ms. Fulk and Gil Margolin; (ii) for 2022, Ms. Jennifer Fulk and Messrs. Gil Margolin and John Reilly; and (iii) for 2021, Ms. Jennifer Fulk, Ms. Samara Braunstein, Ms. Roni Frank, and Messrs. Mark Hirschhorn, Gil Margolin, and John Reilly.
    35

    (4)
    The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the non-CEO NEOs as a group, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to these NEOs as a group during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the non-CEO NEOs as a group for each year to determine the compensation actually paid, using the same methodology described above in Note 2:
     
     
     
     
     
     
     
     
     
     
     
     
     
    Year
     
     
    Average
    Reported Summary
    Compensation Table
    Total for Non-PEO NEOs
     
     
    Deduct Average
    Reported
    Value of Equity
    Awards
     
     
    Average Equity
    Award Adjustments(a)
     
     
    Average Compensation
    Actually Paid to
    Non-PEO NEOs
    2024
     
     
    $1,378,848
     
     
    $(698,256)
     
     
    $157,908
     
     
    $838,499
     
     
     
     
     
     
     
     
     
     
     
     
     
    (a)
    The amounts deducted or added in calculating the total average equity award adjustments are as follows:
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Year
     
     
    Average
    Year End Fair
    Value of Equity
    Awards
    Outstanding and
    Unvested Granted
    in the Year
     
     
    Year over
    Year Average
    Change in
    Fair Value of
    Outstanding
    and Unvested
    Equity
    Awards
     
     
    Average Fair
    Value as of
    Vesting Date
    of Equity
    Awards Granted
    and Vested
    in the Year
     
     
    Average
    Change in
    Fair Value
    of Equity
    Awards
    Granted in
    Prior Years
    that Vested
    in the Year
     
     
    Average Fair
    Value at the
    End of the
    Prior Year
    of Equity
    Awards
    that Failed
    to Meet
    Vesting
    Conditions
    in the Year
     
     
    Average Value of
    Dividends or
    other
    Earnings Paid
    on Stock or
    Option
    Awards not
    Otherwise
    Reflected in
    Fair Value or
    Total
    Compensation
     
     
    Total
    Average
    Equity
    Award
    Adjustments
    2024
     
     
    $378,087
     
     
    $42,633
     
     
    $105,878
     
     
    $107,949
     
     
    $(476,639)
     
     
    $0
     
     
    $157,908
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    (5)
    Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period.
    (6)
    The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year.
    Analysis of the Information Presented in the Pay versus Performance Table
    In accordance with Item 402(v) of Regulation S-K, the Company is providing the following descriptions of the relationships between information presented in the Pay Versus Performance table.
    Compensation Actually Paid vs. Cumulative Total Shareholder Return (“TSR”)
    Given the turnover in executive leadership during 2022, the relationship between compensation actually paid, as presented in the table above, and TSR may not align. As senior leadership stabilized in 2023, TSR increased and actual compensation paid to our CEO, as compared to prior CEOs, increased, but actual compensation paid to our non-CEO NEOs as a group decreased from prior periods. In 2024, TSR increased from prior years, but at a slower rate than the increase seen in 2023, while actual compensation paid to our CEO increased, but actual compensation paid to our non-CEO NEOs remained stable. TSR reflects stock price movement, but not all aspects of our performance. Our compensation decisions also consider key strategic and operational goals that we believe will drive long-term shareholder value.
    Compensation Actually Paid vs. Net Income
    Given the turnover in executive leadership during 2022, the relationship between compensation actually paid, as presented in the table above, and Net Income may not align. As senior leadership stabilized in 2023, net losses were less than in prior periods. Actual compensation paid to our CEO, as compared to prior CEOs, increased, but actual compensation paid to our non-CEO NEOs as a group decreased from prior periods. In 2024, net losses improved in comparison to 2023, leading to the Company reaching profitability for the first time in its history. Actual compensation paid to our CEO, increased, but actual compensation paid to our non-CEO NEOs remained stable.
    36

    Equity Compensation Plan Information
    The following table sets forth information as of December 31, 2024 with respect to shares of our common stock authorized for issuance under our 2021 Plan.
     
     
     
     
     
     
     
     
     
     
    Plan category:
     
     
    Number of Securities
    to
    be Issued Upon
    Exercise
    of Outstanding
    Options,
    Warrants, and Rights
    and Vesting of Stock
    Awards(1)
     
     
    Weighted-Average
    Exercise Price of
    Outstanding Options,
    Warrants, and Rights
     
     
    Number of Securities
    Available for Future
    Issuance Under Equity
    Compensation Plans
    (excludes securities
    Reflected in first
    column)(2)
    Equity compensation plans not approved by security holders
     
     
    —
     
     
    —
     
     
    —
    Equity compensation plans approved by security holders
     
     
    16,752,170
     
     
    $2.93
     
     
    9,853,652
    Total
     
     
    16,752,170
     
     
    $2.93
     
     
    9,853,652
     
     
     
     
     
     
     
     
     
     
    37

    2024 DIRECTOR COMPENSATION
     
     
     
     
     
     
     
     
     
     
     
     
     
    Name
     
     
    Fees Earned or
    Paid in Cash
    ($)
     
     
    Option Awards
    ($)(1)(3)
     
     
    Stock Awards
    ($)(1)(6)
     
     
    Total
    ($)
    Douglas L. Braunstein
     
     
    70,000(2)
     
     
    —
     
     
    160,189
     
     
    230,189
    Erez Shachar
     
     
    50,000(3)
     
     
    —
     
     
    160,189
     
     
    210,189
    Curtis Warfield
     
     
    60,000
     
     
    —
     
     
    160,189
     
     
    220,189
    Jacqueline Yeaney
     
     
    40,000
     
     
    —
     
     
    160,189
     
     
    200,189
    Madhu Pawar
     
     
    40,000(4)
     
     
    —
     
     
    160,189
     
     
    200,189
    Michael Hansen
     
     
    40,000
     
     
    —
     
     
    160,189
     
     
    200,189
    Liat Ben-Zur
     
     
    40,000
     
     
    —
     
     
    160,189
     
     
    200,189
    Swati Abbott
     
     
    40,000(5)
     
     
    —
     
     
    160,189
     
     
    200,189
     
     
     
     
     
     
     
     
     
     
     
     
     
    (1)
    Amounts reflect the full grant-date fair value of RSUs and stock options granted during 2024 computed in accordance with ASC Topic 718, rather than the amounts paid to or realized by the named individual. We provide information regarding the assumptions used to calculate the value of all RSUs and option awards made to our directors in Note 10 to the consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.
    (2)
    Mr. Brauntsein elected to receive his cash retainer fees payable in the form of RSUs. As a result, Mr. Braunstein was granted: (i) 6,014 RSUs on March 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $17,982, (ii) 6,406 RSUs on June 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $16,784, (iii) 9,440 RSUs on September 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $18,80, and (iv) 5,123 RSUs on December 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $17,521.
    (3)
    Mr. Shachar elected to receive his cash retainer fees payable in the form of RSUs. As a result, Mr. Shachar was granted: (i) 4,296 RSUs on March 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $12,845, (ii) 4,576 RSUs on June 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $11,989, (iii) 6,743 RSUs on September 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $13,486, and (iv) 3,660 RSUs on December 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $12,517.
    (4)
    Ms. Pawar elected to receive her cash retainer fees payable in the form of RSUs. As a result, Ms. Pawar was granted: (i) 3,437 RSUs on March 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $10,277, (ii) 3,661 RSUs on June 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $9,592, (iii) 5,394 RSUs on September 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $10,788, and (iv) 2,928 RSSUs on December 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of 10,014.
    (5)
    Ms. Abbott elected to receive her cash retainer fees payable in the form of RSUs. As a result, Ms. Abbott was granted: (i) 3,437 RSUs on March 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $10,277, (ii) 3,661 RSUs on June 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $9,592, (iii) 5,394 RSUs on September 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of $10,788, and (iv) 2,928 RSSUs on December 1, 2024, having a grant date value, as computed in accordance with ASC Topic 718, of 10,014.
    (6)
    The table below shows the aggregate numbers of option awards (exercisable and unexercisable) and unvested stock awards held as of December 31, 2024 by each non-employee director.
     
     
     
     
     
     
     
    Name
     
     
    Option Awards
    Outstanding at 2024
    Fiscal Year End
     
     
    Unvested Stock Awards
    Outstanding at 2024
    Fiscal Year End
    Jon R. Cohen(1)
     
     
    1,314,262
     
     
    1,581,587
    Douglas L. Braunstein
     
     
    703,402
     
     
    50,685
    Erez Shachar
     
     
    63,402
     
     
    50,685
    Curtis Warfield
     
     
    63,402
     
     
    50,685
    Jacqueline Yeaney
     
     
    63,402
     
     
    50,685
    Madhu Pawar
     
     
    63,402
     
     
    50,685
    Michael Hansen
     
     
    200,211
     
     
    86,222
    Swati Abbott
     
     
    57,985
     
     
    92,751
    Liat Ben-Zur
     
     
    57,985
     
     
    92,751
     
     
     
     
     
     
     
    (1)
    Dr. Cohen serves as our Chief Executive Officer since November 2022; as such, his compensation earned as a director is disclosed in the Summary Compensation Table and his outstanding equity awards are disclosed in the Outstanding Equity Awards at Fiscal Year End table.
    The Director Compensation Program provides for annual retainer fees and long-term equity awards for certain of our non-employee directors (each, an “Eligible Director”). The material terms of the Director Compensation Program are summarized below.
    38

    Cash Compensation
    •
    Annual Retainer: $40,000
    •
    Annual Committee Chair Retainer:
    ○
    Audit: $20,000
    ○
    Compensation: $10,000
    •
    Annual Chairman Retainer: $30,000
    Annual cash retainers will be paid in quarterly installments in arrears and will be pro-rated for any partial calendar quarter of service. For the fiscal year ended December 31, 2024, Douglas Braunstein, Erez Shachar, Madhu Pawar and Swati Abbott each elected to receive the value of their cash compensation amount in the form of RSUs pursuant to an amendment to the Non-Employee Director Compensation Program approved by the Board in November 2023 allowing each non-employee director to elect to receive the value of each of their respective cash compensation amounts in the form of RSUs.
    Equity Compensation
    Annual Grant: An Eligible Director who is serving on the Board as of the date of the annual meeting of the Company’s stockholders each calendar year beginning with calendar year 2022 are granted, on such annual meeting date, a RSU award with a value of approximately $160,000 (each, an “Annual Grant”). Each Annual Grant will vest in full on the earlier to occur of (A) the first anniversary of the applicable grant date and (B) the date of the next annual meeting following the grant date, subject to such Eligible Director’s continued service through the applicable vesting date.
    Initial Grant: Each Eligible Director who is initially elected or appointed to serve on our Board at any time after the closing of the Business Combination will automatically be granted on such election or appointment date (i) a stock option award with a value of up to $320,000 and (ii) a RSU award with a value of up to $80,000 (each, an “Initial Grant”). Each Initial Grant will vest as to 25% of the shares subject to the applicable award on each of the first four anniversaries of the grant date of the applicable award, subject to the Eligible Director’s continued service through the applicable vesting date.
    In addition, each Existing Director Grant, Annual Grant and Initial Grant will vest in full upon a change in control of our company (as defined in the 2021 Plan) if the Eligible Director will not become, as of immediately following the change in control, a member of the Board of the surviving entity or the ultimate parent of the surviving entity.
    Compensation under our Director Compensation Program will be subject to the annual limits on non-employee director compensation set forth in the 2021 Plan.
    39

    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
     
    The following table sets forth information with respect to the beneficial ownership of our common stock for:
    •
    stockholders who beneficially own more than 5% of the outstanding shares of our common stock;
    •
    each of our directors and director nominees;
    •
    each of our NEOs; and
    •
    all of our executive officers and directors as a group.
    The number of shares beneficially owned by each stockholder is determined under rules issued by the SEC and includes voting or investment power with respect to securities. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting thereof, or to dispose or direct the disposition thereof or has the right to acquire such powers within 60 days.
    Unless otherwise noted, the business address of each of those listed in the table below is 622 Third Avenue, New York, New York 10017. We have based our calculation of the percentage of beneficial ownership on 167,368,089 shares of our common stock outstanding as of April 21, 2025.
    Unless otherwise indicated, we believe, based on information provided to us, that each of the stockholders listed below has sole voting and investment power with respect to the shares beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable.
     
     
     
     
     
     
     
    Name and Address of Beneficial Owner
     
     
    Number of Shares(1)
     
     
    % of Ownership
    5% Holders
     
     
     
     
     
     
    HEC Master Fund LP(2)
     
     
    23,525,046
     
     
    14.14%
    Norwest Venture Partners XIII, LP(3)
     
     
    14,702,972
     
     
    8.8%
    Goldman Sachs Group, Inc.(4)
     
     
    8,355,680
     
     
    5.0%
    Qumra Capital II, L.P.(5)
     
     
    8,573,437
     
     
    5.1%
    Directors and Named Executive Officers
     
     
     
     
    Jon Cohen(6)
     
     
    1,590,754
     
     
    1.0%
    Ian Harris(7)
     
     
    219,518
     
     
    *
    Gil Margolin(8)
     
     
    520,366
     
     
    *
    Douglas L. Braunstein(9)
     
     
    25,834,742
     
     
    15.8%
    Erez Shachar(10)
     
     
    88,620,988
     
     
    5.2%
    Curtis Warfield(11)
     
     
    200,026
     
     
    *
    Jacqueline Yeaney(12)
     
     
    305,476
     
     
    *
    Madhu Pawar(13)
     
     
    324,483
     
     
    *
    Michael Hansen(14)
     
     
    217,842
     
     
    *
    Swati Abbott(15)
     
     
    45,219
     
     
    *
    Liat Ben-Zur(16)
     
     
    14,496
     
     
    *
    All current directors and executive officers as a group (13 individuals)(14)
     
     
    39,398,142
     
     
    23.5%
     
     
     
     
     
     
     
    *
    Less than 1%
    (1)
    Shares of common stock beneficially owned for the directors and executive officers includes shares of common stock held as of the date of the table, stock options that are vested as of the date of the table, and stock options and RSUs that will vest within 60 days following the date of the table.
    (2)
    Based on information reported on a Schedule 13D/A filed on November 17, 2021, a Form 4 filed on March 5, 2024 and information known to the Company, consists of (i) 11,340,600 shares of common stock and 7,640,000 shares of common stock issuable upon the exercise of warrants held by HEC Master Fund LP, (ii) 2,274,446 shares of common stock owned jointly among Douglas Braunstein and his spouse (Samara Braunstein), including through a trust, (iii) 1,963,223 shares of common stock held directly by Mr. Braunstein, (iv) 687,551,760 shares of common stock held directly by Mr. Braunstein issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025 and (v) 2,270,000 shares of common stock beneficially owned jointly among Mr. Braunstein and his spouse (Samara Braunstein) through the ownership of warrants exercisable within 60 days of the date of April 21, 2025. Douglas Braunstein is the Managing Member of HEC Management GP LLC (“MGT GP”). MGT GP is the Managing Member of HEC Performance GP LLC and the Managing Partner of Hudson Executive Capital LP, which is the Investment Manager of the HEC Master Fund LP. Hudson Executive Capital LP and Mr. Braunstein disclaims beneficial ownership of the securities owned by HEC Master Fund LP except to the extent of his pecuniary interest therein. The address of HEC Master Fund LP is c/o Walkers Corporate Limited, 190 Elgin Avenue George Town, Grand Cayman KY1-9001.
    40

    (3)
    Based on information reported on a Schedule 13G filed on February 14, 2024, consists of shares of common stock held by Norwest Venture Partners XIII, LP (“NVP XIII”). Genesis VC Partners XIII, LLC is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC, the managing member of Genesis VC Partners XIII, LLC and each of Promod Haque, Jeffrey Crowe and Jon Kossow, as Co-Chief Executive Officers of NVP Associates, LLC and members of the general partner, may be deemed to share voting and dispositive power over the shares held by NVP XIII. Such persons and entities disclaim beneficial ownership of the shares held by NVP XIII, except to the extent of any proportionate pecuniary interest therein.
    (4)
    Based on information reported on a Schedule 13G filed on February 9, 2024, consists of shares of common stock held by the Goldman Sachs Group, Inc. (“GS Group”) and Goldman Sachs & Co. LLC (“Goldman Sachs”). GS Group is the parent holding company of GS LLC, and thus these shares may be deemed to be beneficially owned by Goldman Sachs and Goldman Sachs may be deemed to have sole voting and dispositive power over the shares held by GS Group The address of Goldman Sachs is 200 West Street New York, NY 10282.
    (5)
    Based on information reported on a Schedule 13D filed on July 1, 2021, consists of shares of common stock held by Qumra Capital II, L.P (“Qumra II”). Qumra Capital GP II, L.P. (“Qumra GP II”) is the general partner of Qumra II and Qumra Capital Israel I Ltd. (“Qumra Capital Ltd.”) is the general partner of Qumra GP II. Boaz Dinte and Erez Shachar serve as the managing partners of Qumra Capital Ltd. and share voting and dispositive power with respect to the shares held by Qumra II. Mr. Shachar serves as a member of our board of directors. The address for these entities is c/o Qumra Capital, HaNevi’im St 4, Tel Aviv-Yafo, Israel.
    (6)
    Consists of (i) 781,471 shares of common stock and (ii) 809,283 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    (7)
    Consists of (i) 128,481 shares of common stock and (ii) 91,037 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    (8)
    Consists of (i) 0 shares of common stock and (ii) 520,366 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    (9)
    See footnote 2.
    (10)
    Consists of shares of (i) common stock held by Qumra II, (ii) 0 shares of common stock held by Mr. Shachar and (iii) 47,551 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. Mr. Shachar disclaims beneficial ownership of the shares held of record by Qumra II except to the extent of his pecuniary interest therein. See footnote 5.
    (11)
    Consists of (i) 152,475 shares of common stock and (ii) 47,551 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    (12)
    Consists of (i) 257,925 shares of common stock and (ii) 47,551 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    (13)
    Consists of (i) 276,932 shares of common stock and (ii) 47,551 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    (14)
    Consists of (i) 117,737 shares of common stock and (ii) 100,105 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    (15)
    Consists of (i) 30,723 shares of common stock and (ii) 14,496 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    (16)
    Current directors and executive officers as a group includes the named executive officers and current directors listed in the table above, as well as Mr. John Reilly and Ms. Katelyn Watson. For Mr. Reilly, consists of (i) 666,596 shares of common stock and (ii) 362,321 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025. For Ms. Watson, consists of 100,362 shares of common stock and (ii) 33,875 shares of common stock issuable upon the exercise of options or vesting of restricted stock units, exercisable as of or within 60 days of April 21, 2025.
    41

    POLICIES AND PROCEDURES FOR RELATED PERSON TRANSACTIONS
     
    Our Board of Directors has adopted a written Related Person Transaction Policy, setting forth the policies and procedures for the review and approval or ratification of related person transactions. Under the policy, our finance department is primarily responsible for developing and implementing processes and procedures to obtain information regarding related persons with respect to potential related person transactions and then determining, based on the facts and circumstances, whether such potential related person transactions do, in fact, constitute related person transactions requiring compliance with the policy. If our finance department determines that a transaction or relationship is a related person transaction requiring compliance with the policy, our Chief Financial Officer is required to present to the Audit Committee all relevant facts and circumstances relating to the related person transaction. Our Audit Committee must review the relevant facts and circumstances of each related person transaction, including if the transaction is on terms comparable to those that could be obtained in arm’s length dealings with an unrelated third party and the extent of the related person’s interest in the transaction, take into account the conflicts of interest and corporate opportunity provisions of our Code of Business Conduct and Ethics, and either approve or disapprove the related person transaction. If advance Audit Committee approval of a related person transaction requiring the Audit Committee’s approval is not feasible, then the transaction may be preliminarily entered into by management upon prior approval of the transaction by the chair of the Audit Committee subject to ratification of the transaction by the Audit Committee at the Audit Committee’s next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. If a transaction was not initially recognized as a related person transaction under the Company’s Related Person Transaction Policy, then upon such recognition the transaction will be presented to the Audit Committee for ratification at the Audit Committee’s next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. No director may participate in approval of a related person transaction for which he or she is a related person.
    TRANSACTIONS RELATED TO DIRECTORS, EQUITY HOLDERS AND EXECUTIVE OFFICERS
     
    Registration Rights Agreement
    At the closing of the Business Combination, HEC, the HEC Sponsor LLC (the “Sponsor”), Talkspace’s independent directors, certain former stockholders of Talkspace and certain other parties thereto entered into an Amended and Restated Registration Rights Agreement, pursuant to which Talkspace, Inc. agreed to register for resale, pursuant to Rule 415 under the Securities Act, certain shares of Talkspace common stock and other equity securities of Talkspace that are held by the parties thereto from time to time.
    Director and Officer Indemnification
    Our Certificate of Incorporation provides for indemnification and advancement of expenses for our directors and officers to the fullest extent permitted by the DGCL, subject to certain limited exceptions. In addition, we have entered into indemnification agreements with each director and executive officer of Talkspace, Inc.
    42

    OTHER MATTERS
    DELINQUENT SECTION 16(A) REPORTS
     
    Section 16(a) of the Exchange Act requires our executive officers and directors and persons who beneficially own more than 10% of our common stock to file with the SEC reports of their ownership and changes in their ownership of our common stock. To our knowledge, based solely on review of the copies of such reports and amendments to such reports with respect to the year ended December 31, 2024 filed with the SEC and on written representations by our directors and executive officers, all required Section 16 reports under the Exchange Act for our directors, executive officers, principal accounting officer and beneficial owners of greater than 10% of our common stock were filed on a timely basis during the year ended December 31, 2024 other than the following forms that were inadvertently filed late: (i) one Form 4 for Jennifer Fulk, which reported two transactions late, (ii) two Form 4s for John Reilly, one reporting one transaction late and one reporting two transactions late; (iii) one Form 4s for Jon Cohen one reporting one transaction late; (iv) one Form 4 for Gil Margolin reporting four transaction late; (v) three Form 4s for Douglas Braunstein, two reporting one transaction late and one reporting two transactions late; (vi) one Form 4 for Jacqueline Yeaney reporting one transaction late; (vii) one Form 4 for Curtis Warfield reporting one transaction late; (viii) three Form 4s for Swati Abbott, two reporting one transaction late and one reporting two transactions late; (ix) one Form 4 for Michael Hansen reporting one transaction late; (x) one Form 4 for Liat Ben-Zur reporting one transaction late; (xi) three Form 4s for Erez Shachar, two reporting one transaction late and one reporting two transactions late; (xii) three Form 4s for Madhu Pawar, two reporting one transaction late and one reporting two transactions late, and (xiii) for Katelyn Watson (a) one Form 3 was filed late, and (b) two Form 4s, one reporting two late transactions and one reporting one late transaction, were filed late.
    COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
     
    During the fiscal year ended December 31, 2024, the members of our Compensation Committee were Michael Hansen, Erez Shachar and Curtis Warfield. Each current member of the Compensation Committee is an independent director. None of the members of our Compensation Committee is a current or former employee or served on the board of directors of any other company any of whose executive officers served on the Company’s Compensation Committee or its Board.
    STOCKHOLDERS’ PROPOSALS
     
    Stockholders who intend to have a proposal considered for inclusion in our proxy materials for presentation at our 2026 Annual Meeting of Stockholders pursuant to Rule 14a-8 under the Exchange Act must submit the proposal to our offices at 622 Third Avenue, New York, New York 10017 in writing not later than December 31, 2025.
    Our Bylaws establish an advance notice procedure for stockholders who wish to present a proposal before an annual meeting of stockholders. Our Bylaws provide that the only business that may be conducted at an annual meeting of stockholders is business that is (i) specified in the notice of such meeting (or any supplement thereto) given by or at our Board’s direction, (ii) otherwise properly brought before such meeting by our Board or by the Chairperson of the Board, or (iii) otherwise properly brought before such meeting by a stockholder present in person who (A) (1) was a record owner of our Common Stock both at the time of giving the notice and at the time of such meeting, (2) is entitled to vote at such meeting, and (3) has complied with notice procedures specified in our Bylaws in all applicable respects or (B) properly made such proposal in accordance with Rule 14a-8 under the Exchange Act. To be timely for our annual meeting of stockholders, a stockholders’ notice must be delivered to, or mailed and received at, the principal executive offices of the corporation not less than 90 days nor more than 120 days prior to the one-year anniversary of the preceding year’s annual meeting. Therefore, we must receive notice of such a proposal or nomination for the 2026 Annual Meeting of Stockholders no earlier than the close of business on February 18th, 2026 and no later than the close of business on March 20th, 2026. However, in the event that the date of the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the 90th day prior to such annual meeting or, if later, the 10th day following the day on which public disclosure of the date of such annual meeting was first made by the corporation. In no event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of timely notice as described above.
    Nominations and proposals also must satisfy other requirements set forth in the Bylaws.
    43

    Stockholder Director Nominees
    Our Bylaws permit stockholders to nominate directors for election at an annual meeting or at a special meeting (but only if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting) of stockholders. To nominate a director, the stockholder must comply with the requirements in the Bylaws and provide the information required by our Bylaws. In addition, the stockholder must give timely notice to our corporate secretary in accordance with our Bylaws. To be timely for our annual meeting of stockholders, a stockholders’ notice of nomination must be delivered to, or mailed and received at, the principal executive offices of the corporation not less than 90 days nor more than 120 days prior to the one-year anniversary of the preceding year’s annual meeting. Therefore, we must receive notice of such a proposal or nomination for the 2026 Annual Meeting of Stockholders no earlier than the close of business on February 18th, 2026 and no later than the close of business on March 20th, 2026. However, in the event that the date of the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the 90th day prior to such annual meeting or, if later, the 10th day following the day on which public disclosure of the date of such annual meeting was first made by the corporation. In no event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period (or extend any time period) for the giving of timely notice as described above. SEC rules permit management to vote proxies in its discretion in certain cases if the stockholder does not comply with this deadline and, in certain other cases notwithstanding the stockholder’s compliance with this deadline.
    In addition to satisfying the foregoing requirements under the Company’s Bylaws, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide the information required by Rule 14a-19 under the Exchange Act by the dates described above for stockholder nominations.
    We reserve the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these or other applicable requirements.
    OTHER MATTERS AT THE ANNUAL MEETING
     
    Our Board is not aware of any matter to be presented for action at the Annual Meeting other than the matters referred to above and does not intend to bring any other matters before the Annual Meeting. However, if other matters should come before the Annual Meeting, it is intended that holders of the proxies will vote thereon in their discretion.
    SOLICITATION OF PROXIES
     
    The accompanying proxy is solicited by and on behalf of our Board, whose Notice of Annual Meeting is attached to this proxy statement, and the entire cost of our solicitation will be borne by us. In addition to the use of mail, proxies may be solicited by personal interview, telephone, e-mail and facsimile by our directors, officers and other employees who will not be specially compensated for these services. We will also request that brokers, nominees, custodians and other fiduciaries forward soliciting materials to the beneficial owners of shares held by the brokers, nominees, custodians and other fiduciaries. We will reimburse these persons for their reasonable expenses in connection with these activities.
    TALKSPACE’S ANNUAL REPORT ON FORM 10-K
     
    A copy of Talkspace’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, including financial statements but not including exhibits, as filed with the SEC, will be sent to any stockholder of record on April 21, 2025 without charge upon written request addressed to Talkspace, Inc., Attention: Legal Department, P.O. Box 659, Portsmouth, NH, 03802. A reasonable fee will be charged for copies of exhibits. You also may access our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 at www.talkspace.com.
    44

    WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING, WE URGE YOU TO VOTE YOUR SHARES VIA THE TOLL-FREE TELEPHONE NUMBER OR OVER THE INTERNET, AS DESCRIBED IN THIS PROXY STATEMENT. IF YOU RECEIVED A COPY OF THE PROXY CARD BY MAIL, YOU MAY SIGN, DATE AND MAIL THE PROXY CARD IN THE ENCLOSED RETURN ENVELOPE. PROMPTLY VOTING YOUR SHARES WILL ENSURE THE PRESENCE OF A QUORUM AT THE ANNUAL MEETING AND WILL SAVE US THE EXPENSE OF FURTHER SOLICITATION.
    By Order of the Board of Directors
    /s/ Douglas Braunstein
    Douglas Braunstein
    Chairman of the Board
    New York, New York
    April 30, 2025
    45


     


     
    DEF 14A 0001803901 false 0001803901 2024-01-01 2024-12-31 0001803901 talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 talk:MrBraunsteinMember 2024-01-01 2024-12-31 0001803901 talk:MrCohenMember 2023-01-01 2023-12-31 0001803901 talk:MrBraunsteinMember 2023-01-01 2023-12-31 0001803901 2023-01-01 2023-12-31 0001803901 talk:MrCohenMember 2022-01-01 2022-12-31 0001803901 talk:MrBraunsteinMember 2022-01-01 2022-12-31 0001803901 2022-01-01 2022-12-31 0001803901 2022-11-09 2022-12-31 0001803901 2022-01-01 2022-11-08 0001803901 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember ecd:PeoMember talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:PeoMember talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:PeoMember talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember ecd:PeoMember talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember ecd:PeoMember talk:MrCohenMember 2024-01-01 2024-12-31 0001803901 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001803901 ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001803901 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001803901 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001803901 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001803901 ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001803901 ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 0001803901 ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-31 iso4217:USD
    Get the next $TALK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TALK

    DatePrice TargetRatingAnalyst
    4/3/2025$5.00Buy
    Canaccord Genuity
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    12/4/2024$5.00Outperform
    Mizuho
    11/20/2024$5.00Outperform
    Northland Capital
    7/1/2024Hold
    Needham
    1/3/2024$2.50Equal Weight
    Barclays
    12/2/2021$2.00Hold
    Jefferies
    11/16/2021$10.00 → $3.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Navigate Drives Continued Momentum in its Partner Ecosystem; Adds Talkspace, movr, and Springbuk

      WEST DES MOINES, Iowa, May 7, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced strategic partnerships with Talkspace (NASDAQ:TALK), movr, and Springbuk, adding significant strength to its partner ecosystem. These leading solutions address three of the most urgent and costly areas in workforce health: mental health, musculoskeletal (MSK) care, and population health intelligence. "Employers are no longer willing to take a trial-and-error approach to employee health benefits," stated Troy Vincent, Founder and CEO of Navigate Wellbeing Solutions. "Our wellbeing solution

      5/7/25 11:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Announces First Quarter 2025 Results

      1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

      5/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace and Bark Technologies Partner to Equip Teens with Essential Mental Health Resources Right from Their Bark Phones

        Talkspace (NASDAQ:TALK), a leading online behavioral healthcare company, and Bark Technologies, the leader in online safety tech for kids, announced they will join forces to help families navigate the many challenges facing teens today. Starting May 1, this new partnership will make Talkspace's high-quality mental health resources available to Bark Phone and Bark app users, as well as provide an enterprise-level solution that leverages their unique capabilities. Talkspace complements Bark's advanced content monitoring, which helps families detect potential dangers in their children's online activities, putting mental health support at their fingertips by connecting teens (13+) to resou

      4/29/25 9:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    SEC Filings

    See more
    • SEC Form 10-Q filed by Talkspace Inc.

      10-Q - Talkspace, Inc. (0001803901) (Filer)

      5/9/25 8:38:38 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Talkspace, Inc. (0001803901) (Filer)

      5/6/25 8:15:44 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by Talkspace Inc.

      DEFA14A - Talkspace, Inc. (0001803901) (Filer)

      4/30/25 5:26:18 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity initiated coverage on Talkspace with a new price target

      Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

      4/3/25 8:18:33 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Talkspace with a new price target

      KeyBanc Capital Markets initiated coverage of Talkspace with a rating of Overweight and set a new price target of $4.50

      12/9/24 8:34:29 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Mizuho initiated coverage on Talkspace with a new price target

      Mizuho initiated coverage of Talkspace with a rating of Outperform and set a new price target of $5.00

      12/4/24 7:49:48 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Harris Ian Jiro bought $86,037 worth of shares (30,844 units at $2.79), increasing direct ownership by 5% to 615,015 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/5/25 4:00:06 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/3/25 9:30:03 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Legal Officer, Secretary Reilly John Charles bought $10,242 worth of shares (3,600 units at $2.85), increasing direct ownership by 0.41% to 889,806 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      2/28/25 9:55:04 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

      SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

      2/14/24 4:24:23 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

      SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

      2/9/24 7:24:33 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

      SC 13D/A - Talkspace, Inc. (0001803901) (Subject)

      10/5/23 6:41:35 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Cohen Jon R covered exercise/tax liability with 53,601 shares, decreasing direct ownership by 2% to 2,573,060 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/11/25 8:00:16 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Marketing Officer Watson Katelyn covered exercise/tax liability with 2,779 shares, decreasing direct ownership by 0.58% to 472,997 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/11/25 8:00:13 PM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Chief Legal Officer, Secretary Reilly John Charles covered exercise/tax liability with 12,521 shares, decreasing direct ownership by 1% to 1,040,035 units (SEC Form 4)

      4 - Talkspace, Inc. (0001803901) (Issuer)

      3/11/25 8:00:08 PM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Financials

    Live finance-specific insights

    See more
    • Talkspace Announces First Quarter 2025 Results

      1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

      5/6/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace to Report First Quarter 2025 Results and Host Conference Call

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that it will release its first quarter 2025 results on Tuesday, May 6, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and referencing participant code 1021845. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About Talkspace

      4/16/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Announces Fourth Quarter and Full Year 2024 Results

      Full year 2024 total revenue grew 25% year-over-year to $187.6 millionFull year 2024 net income of $1.1 million and adjusted EBITDA1 of $7.0 million 4Q 2024 total revenue grew 15% year-over-year to $48.7 million4Q 2024 net income of $1.2 million and adjusted EBITDA1 of $2.7 million NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported fourth quarter and full year 2024 financial results.     Three Months Ended December 31, 2024 Year Ended December 31, 2024     Unaudited Results % Variance from Prior Year Results % Variance from Prior Year(In thousands unless otherwise noted)        Number of eligible lives at ye

      2/20/25 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care

    $TALK
    Leadership Updates

    Live Leadership Updates

    See more
    • Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

      New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

      9/17/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

      Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

      8/28/24 9:06:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care
    • Talkspace Appoints John Mooney as Chief Product Officer

      NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Today Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced the appointment of John Mooney as its new Chief Product Officer, to lead the company's growth initiatives, product strategy and design. Through his work for startup digital health, behavioral health, and diagnostics companies, Mr. Mooney has deep domain expertise in healthcare data, building out platform capabilities and optimizing workflows. "John has spent his career driving innovation for a range of high-growth, high-performing healthcare companies," said Dr. Jon Cohen, Chief Executive Officer, Talkspace. "We look forward to his expertise leveraging dat

      6/5/24 8:00:00 AM ET
      $TALK
      Medical/Nursing Services
      Health Care